UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)



☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, ~~2020~~2021



☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-50976

HURON CONSULTING GROUP INC.

(Exact name of registrant as specified in its charter)



~~Delaware~~

	~~01-0666114~~
Delaware		01-0666114
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification Number)

550 West Van Buren Street

Chicago,, Illinois

60607

(Address of principal executive offices)

(Zip Code)

(312)583-8700

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	HURN	NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

☒

Accelerated Filer

☐

Non-accelerated Filer

☐

Smaller Reporting

Company

☐

Emerging Growth Company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of April ~~23, 2020, 22,849,043~~27, 2021, 22,577,906 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.

Table of Contents

~~Table of Contents~~

Huron Consulting Group Inc.

HURON CONSULTING GROUP INC.

INDEX

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

HURON CONSULTING GROUP INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)


	March 31, 2020			December 31, 2019				March 31, 2021		December 31, 2020
Assets							Assets
Current assets:							Current assets:
Cash and cash equivalents	$	151,009		$	11,604		Cash and cash equivalents	$	21,623	$	67,177
Receivables from clients, net of allowances of $9,187 and $8,907, respectively	105,379			116,571
Unbilled services, net of allowances of $3,356 and $2,994, respectively	88,960			79,937
Receivables from clients, net of allowances of $8,464 and $7,680, respectively							Receivables from clients, net of allowances of $8,464 and $7,680, respectively	87,146		87,687
Unbilled services, net of allowances of $2,969 and $2,603, respectively							Unbilled services, net of allowances of $2,969 and $2,603, respectively	77,080		53,959
Income tax receivable	748			2,376			Income tax receivable	4,403		5,121
Prepaid expenses and other current assets	13,309			14,248			Prepaid expenses and other current assets	14,964		16,569
Total current assets	359,405			224,736			Total current assets	205,216		230,513
Property and equipment, net	38,326			38,413			Property and equipment, net	29,710		29,093
Deferred income taxes, net	8,334			1,145			Deferred income taxes, net	5,303		4,191
Long-term investment	67,194			54,541
Long-term investments							Long-term investments	64,703		71,030
Operating lease right-of-use assets	52,849			54,954			Operating lease right-of-use assets	38,207		39,360
Other non-current assets	49,578			52,177			Other non-current assets	62,819		62,068
Intangible assets, net	28,127			31,625			Intangible assets, net	21,232		20,483
Goodwill	586,235			646,680			Goodwill	597,552		594,237
Total assets	$	1,190,048		$	1,104,271		Total assets	$	1,024,742	$	1,050,975
Liabilities and stockholders’ equity							Liabilities and stockholders’ equity
Current liabilities:							Current liabilities:
Accounts payable	$	5,799		$	7,944		Accounts payable	$	8,156	$	648
Accrued expenses and other current liabilities	21,580			18,554			Accrued expenses and other current liabilities	16,302		14,874
Accrued payroll and related benefits	53,380			141,605			Accrued payroll and related benefits	56,811		133,830
Current maturities of long-term debt	533			529			Current maturities of long-term debt	548		499
Current maturities of operating lease liabilities	8,206			7,469			Current maturities of operating lease liabilities	9,671		8,771
Deferred revenues	30,010			28,443			Deferred revenues	18,686		28,247
Total current liabilities	119,508			204,544			Total current liabilities	110,174		186,869
Non-current liabilities:							Non-current liabilities:
Deferred compensation and other liabilities	26,854			28,635			Deferred compensation and other liabilities	43,947		45,361
Accrued contingent consideration for business acquisitions							Accrued contingent consideration for business acquisitions	1,812		1,770
Long-term debt, net of current portion	451,189			208,324			Long-term debt, net of current portion	267,642		202,780
Operating lease liabilities, net of current portion	67,317			69,233			Operating lease liabilities, net of current portion	59,730		61,825
Deferred income taxes, net	571			8,070			Deferred income taxes, net	434		428
Total non-current liabilities	545,931			314,262			Total non-current liabilities	373,565		312,164
Commitments and contingencies							Commitments and contingencies	0		0
Stockholders’ equity							Stockholders’ equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,391,801 and 25,144,764 shares issued at March 31, 2020 and December 31, 2019, respectively	246			247
Treasury stock, at cost, 2,546,566 and 2,425,430 shares at March 31, 2020 and December 31, 2019, respectively	(128,366		)	(128,348		)
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,294,954 and 25,346,916 shares issued at March 31, 2021 and December 31, 2020, respectively							Common stock; $0.01 par value; 500,000,000 shares authorized; 25,294,954 and 25,346,916 shares issued at March 31, 2021 and December 31, 2020, respectively	247		246
Treasury stock, at cost, 2,422,227 and 2,584,119 shares at March 31, 2021 and December 31, 2020, respectively							Treasury stock, at cost, 2,422,227 and 2,584,119 shares at March 31, 2021 and December 31, 2020, respectively	(134,611)		(129,886)
Additional paid-in capital	444,974			460,781			Additional paid-in capital	445,711		454,512
Retained earnings	195,541			237,849			Retained earnings	219,414		214,009
Accumulated other comprehensive income	12,214			14,936			Accumulated other comprehensive income	10,242		13,061
Total stockholders’ equity	524,609			585,465			Total stockholders’ equity	541,003		551,942
Total liabilities and stockholders’ equity	$	1,190,048		$	1,104,271		Total liabilities and stockholders’ equity	$	1,024,742	$	1,050,975

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)

(In thousands, except per share amounts)

(Unaudited)


	Three Months Ended March 31,							Three Months Ended March 31,
	2020			2019					2021		2020
Revenues and reimbursable expenses:							Revenues and reimbursable expenses:
Revenues	$	222,619		$	204,445		Revenues		$	203,213	$	222,619
Reimbursable expenses	19,303			18,617			Reimbursable expenses		1,934		19,303
Total revenues and reimbursable expenses	241,922			223,062			Total revenues and reimbursable expenses		205,147		241,922
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):							Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):
Direct costs	156,248			137,780			Direct costs		148,115		156,248
Amortization of intangible assets and software development costs	1,301			1,117			Amortization of intangible assets and software development costs		925		1,301
Reimbursable expenses	19,389			18,669			Reimbursable expenses		2,003		19,389
Total direct costs and reimbursable expenses	176,938			157,566			Total direct costs and reimbursable expenses		151,043		176,938
Operating expenses and other losses (gains), net							Operating expenses and other losses (gains), net
Selling, general and administrative expenses	43,446			50,749			Selling, general and administrative expenses		39,766		43,446
Restructuring charges	1,609			1,275			Restructuring charges		628		1,609
Litigation and other gains	(150		)	(456		)
Litigation and other losses (gains)							Litigation and other losses (gains)		42		(150)
Depreciation and amortization	6,114			7,172			Depreciation and amortization		5,428		6,114
Goodwill impairment charges	59,816			—			Goodwill impairment charges		0		59,816
Total operating expenses and other losses (gains), net	110,835			58,740			Total operating expenses and other losses (gains), net		45,864		110,835
Operating income (loss)	(45,851		)	6,756			Operating income (loss)		8,240		(45,851)
Other income (expense), net:							Other income (expense), net:
Interest expense, net of interest income	(2,341		)	(4,258		)	Interest expense, net of interest income		(1,719)		(2,341)
Other income (expense), net	(5,296		)	2,217			Other income (expense), net		420		(5,296)
Total other expense, net	(7,637		)	(2,041		)	Total other expense, net		(1,299)		(7,637)
Income (loss) from continuing operations before taxes	(53,488		)	4,715			Income (loss) from continuing operations before taxes		6,941		(53,488)
Income tax expense (benefit)	(11,215		)	1,365			Income tax expense (benefit)		1,536		(11,215)
Net income (loss) from continuing operations	(42,273		)	3,350			Net income (loss) from continuing operations		5,405		(42,273)
Loss from discontinued operations, net of tax	(35		)	(46		)	Loss from discontinued operations, net of tax		0		(35)
Net income (loss)	$	(42,308	)	$	3,304		Net income (loss)		$	5,405	$	(42,308)
Net earnings (loss) per basic share:							Net earnings (loss) per basic share:
Net income (loss) from continuing operations	$	(1.94	)	$	0.15		Net income (loss) from continuing operations		$	0.25	$	(1.94)
Loss from discontinued operations, net of tax	—			—			Loss from discontinued operations, net of tax		0		0
Net income (loss)	$	(1.94	)	$	0.15		Net income (loss)		$	0.25	$	(1.94)
Net earnings (loss) per diluted share:							Net earnings (loss) per diluted share:
Net income (loss) from continuing operations	$	(1.94	)	$	0.15		Net income (loss) from continuing operations		$	0.24	$	(1.94)
Loss from discontinued operations, net of tax	—			—			Loss from discontinued operations, net of tax		0		0
Net income (loss)	$	(1.94	)	$	0.15		Net income (loss)		$	0.24	$	(1.94)
Weighted average shares used in calculating earnings (loss) per share:							Weighted average shares used in calculating earnings (loss) per share:
Basic	21,827			21,868			Basic		21,932		21,827
Diluted	21,827			22,311			Diluted		22,341		21,827
Comprehensive income:
Comprehensive income (loss):							Comprehensive income (loss):
Net income (loss)	$	(42,308	)	$	3,304		Net income (loss)		$	5,405	$	(42,308)
Foreign currency translation adjustments, net of tax	(779		)	316			Foreign currency translation adjustments, net of tax		400		(779)
Unrealized gain (loss) on investment, net of tax	(258		)	2,657
Unrealized loss on cash flow hedging instruments, net of tax	(1,685		)	(237		)
Other comprehensive income (loss)	(2,722		)	2,736
Unrealized loss on investment, net of tax							Unrealized loss on investment, net of tax		(4,648)		(258)
Unrealized gain (loss) on cash flow hedging instruments, net of tax							Unrealized gain (loss) on cash flow hedging instruments, net of tax		1,429		(1,685)
Other comprehensive loss							Other comprehensive loss		(2,819)		(2,722)
Comprehensive income (loss)	$	(45,030	)	$	6,040		Comprehensive income (loss)		$	2,586	$	(45,030)

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share amounts)

(Unaudited)


																											Three Months Ended March 31, 2021
	Three Months Ended March 31, 2020																										Common Stock						Treasury Stock			Additional Paid-In Capital				Retained Earnings		Accumulated Other Comprehensive Income		Stockholders’ Equity
	Common Stock					Treasury Stock					Additional Paid-In Capital				Retained Earnings				Accumulated Other Comprehensive Income			Stockholders’ Equity					Shares			Amount			Shares	Amount
	Shares		Amount			Shares		Amount
Balance at December 31, 2019	24,603,308		$	247		(2,763,302	)	$	(128,348	)				$				460,781								$	237,849	$	14,936		$	585,465
Balance at December 31, 2020																									Balance at December 31, 2020		24,560,855			$	246		(2,812,896)	$	(129,886)			$	454,512			$	214,009	$	13,061	$	551,942
Comprehensive income															(42,308		)		(2,722		)	(45,030		)	Comprehensive income															5,405		(2,819)		2,586
Issuance of common stock in connection with:																									Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	250,544		2			102,467		7,115			(7,117		)									—			Restricted stock awards, net of cancellations		376,731			4			90,100	3,778		(3,782)								0
Exercise of stock options	20,000		—								468											468			Exercise of stock options		6,631			—						174								174
Share-based compensation											11,720											11,720			Share-based compensation											7,988								7,988
Shares redeemed for employee tax withholdings						(120,000	)	(7,133		)												(7,133		)	Shares redeemed for employee tax withholdings								(165,203)	(8,503)										(8,503)

Share repurchases	(313,998	)	(3		)						(20,878		)									(20,881		)	Share repurchases		(245,718)			$	(3)					$	(13,181)							(13,184)
Balance at March 31, 2020	24,559,854		$	246		(2,780,835	)	$	(128,366	)	$	444,974			$	195,541			$	12,214		$	524,609
Balance at March 31, 2021																									Balance at March 31, 2021		24,698,499			$	247		(2,887,999)	$	(134,611)	$	445,711			$	219,414	$	10,242	$	541,003


																							Three Months Ended March 31, 2020
	Three Months Ended March 31, 2019																						Common Stock						Treasury Stock			Additional Paid-In Capital				Retained Earnings		Accumulated Other Comprehensive Income		Stockholders’ Equity
	Common Stock			Treasury Stock					Additional Paid-In Capital				Retained Earnings			Accumulated Other Comprehensive Income		Stockholders’ Equity					Shares			Amount			Shares	Amount
	Shares	Amount		Shares		Amount
Balance at December 31, 2018	24,418,252	$	244	(2,671,962	)	$	(124,794	)				$			452,573							$	196,106	$	16,495		$	540,624
Balance at December 31, 2019																					Balance at December 31, 2019		24,603,308			$	247		(2,763,302)	$	(128,348)			$	460,781			$	237,849	$	14,936	$	585,465
Comprehensive income													3,304			2,736		6,040			Comprehensive income															(42,308)		(2,722)		(45,030)
Issuance of common stock in connection with:																					Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	254,550	3		27,612		2,196			(2,199		)							—			Restricted stock awards, net of cancellations		250,544			2			102,467	7,115		(7,117)								0
Exercise of stock options	10,000	—							234									234			Exercise of stock options		20,000			—						468								468
Share-based compensation									7,140									7,140			Share-based compensation											11,720								11,720
Shares redeemed for employee tax withholdings				(94,500	)	(4,385		)										(4,385		)	Shares redeemed for employee tax withholdings								(120,000)	(7,133)										(7,133)
Balance at March 31, 2019	24,682,802	$	247	(2,738,850	)	$	(126,983	)	$	457,748			$	199,410		$	19,231	$	549,653
Share repurchases																					Share repurchases		(313,998)			(3)						(20,878)								(20,881)
Balance at March 31, 2020																					Balance at March 31, 2020		24,559,854			$	246		(2,780,835)	$	(128,366)	$	444,974			$	195,541	$	12,214	$	524,609

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


	Three Months Ended March 31,							Three Months Ended March 31,
	2020			2019				2021		2020
Cash flows from operating activities:							Cash flows from operating activities:
Net income (loss)	$	(42,308	)	$	3,304		Net income (loss)	$	5,405	$	(42,308)
Adjustments to reconcile net income (loss) to cash flows from operating activities:							Adjustments to reconcile net income (loss) to cash flows from operating activities:
Depreciation and amortization	7,415			8,538			Depreciation and amortization	6,567		7,415
Non-cash lease expense	1,938			2,172			Non-cash lease expense	1,693		1,938
Lease impairment charge	—			740

Share-based compensation	8,504			5,366			Share-based compensation	5,625		8,504
Amortization of debt discount and issuance costs	198			2,618			Amortization of debt discount and issuance costs	198		198
Goodwill impairment charges	59,816			—			Goodwill impairment charges	0		59,816
Allowances for doubtful accounts	21			59			Allowances for doubtful accounts	0		21
Deferred income taxes	(14,016		)	—			Deferred income taxes	—		(14,016)
Loss on sale of business	102			—			Loss on sale of business	0		102
Change in fair value of contingent consideration liabilities	—			(391		)	Change in fair value of contingent consideration liabilities	42		0
Changes in operating assets and liabilities, net of divestiture:
Changes in operating assets and liabilities, net of acquisition and divestiture:							Changes in operating assets and liabilities, net of acquisition and divestiture:
(Increase) decrease in receivables from clients, net	11,698			5,129			(Increase) decrease in receivables from clients, net	1,178		11,698
(Increase) decrease in unbilled services, net	(9,138		)	(16,850		)	(Increase) decrease in unbilled services, net	(23,086)		(9,138)
(Increase) decrease in current income tax receivable / payable, net	2,332			3,490			(Increase) decrease in current income tax receivable / payable, net	573		2,332
(Increase) decrease in other assets	4,304			(2,554		)	(Increase) decrease in other assets	327		4,304
Increase (decrease) in accounts payable and other liabilities	(3,708		)	2,396			Increase (decrease) in accounts payable and other liabilities	2,566		(3,708)
Increase (decrease) in accrued payroll and related benefits	(84,910		)	(54,151		)	Increase (decrease) in accrued payroll and related benefits	(74,273)		(84,910)
Increase (decrease) in deferred revenues	1,606			1,845			Increase (decrease) in deferred revenues	(9,569)		1,606
Net cash used in operating activities	(56,146		)	(38,289		)	Net cash used in operating activities	(82,754)		(56,146)
Cash flows from investing activities:							Cash flows from investing activities:
Purchases of property and equipment, net	(1,001		)	(2,349		)	Purchases of property and equipment, net	(637)		(1,001)
Purchases of investment securities	(13,000		)	—			Purchases of investment securities	0		(13,000)
Investment in life insurance policies	(1,472		)	(3,645		)	Investment in life insurance policies	0		(1,472)

Purchases of businesses							Purchases of businesses	(6,000)		0
Capitalization of internally developed software costs	(2,922		)	(2,093		)	Capitalization of internally developed software costs	(1,400)		(2,922)

Net cash used in investing activities	(18,395		)	(8,087		)	Net cash used in investing activities	(8,037)		(18,395)
Cash flows from financing activities:							Cash flows from financing activities:
Proceeds from exercises of stock options	468			234			Proceeds from exercises of stock options	174		468
Shares redeemed for employee tax withholdings	(7,133		)	(4,385		)	Shares redeemed for employee tax withholdings	(8,503)		(7,133)
Share repurchases	(22,115		)	—			Share repurchases	(11,454)		(22,115)
Proceeds from bank borrowings	281,000			40,500			Proceeds from bank borrowings	89,000		281,000
Repayments of bank borrowings	(38,131		)	(14,627		)	Repayments of bank borrowings	(24,135)		(38,131)

Net cash provided by financing activities	214,089			21,722			Net cash provided by financing activities	45,082		214,089
Effect of exchange rate changes on cash	(143		)	73			Effect of exchange rate changes on cash	155		(143)
Net increase (decrease) in cash and cash equivalents	139,405			(24,581		)	Net increase (decrease) in cash and cash equivalents	(45,554)		139,405
Cash and cash equivalents at beginning of the period	11,604			33,107			Cash and cash equivalents at beginning of the period	67,177		11,604
Cash and cash equivalents at end of the period	$	151,009		$	8,526		Cash and cash equivalents at end of the period	$	21,623	$	151,009
Supplemental disclosure of cash flow information:							Supplemental disclosure of cash flow information:
Non-cash investing and financing activities:							Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in accounts payable and accrued expenses	$	3,716		$	1,913
Property and equipment expenditures and capitalized software included in accounts payable, accrued expenses and accrued payroll and related benefits							Property and equipment expenditures and capitalized software included in accounts payable, accrued expenses and accrued payroll and related benefits	$	3,545	$	3,716
Share repurchases included in accounts payable							Share repurchases included in accounts payable	$	1,729	$	0
Deferred payment on business acquisition							Deferred payment on business acquisition	$	1,000	$	0

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

1. Description of Business

Huron is a global consultancy that collaborates with clients to drive strategic growth, ignite innovation and navigate constant change. Through a combination of strategy, expertise and creativity, we help clients accelerate operational, digital and cultural transformation, enabling the change they need to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, ~~we create~~Huron creates sustainable results for the organizations ~~we serve.~~it serves.

2. Basis of Presentation and Significant Accounting Policies

The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three months ended March 31, ~~2020~~2021 and ~~2019.~~2020. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America ("GAAP") for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, ~~2019~~2020 included in our Annual Report on Form 10-K. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

During the first quarter of 2021, we identified an error on our previously reported Consolidated Balance Sheet as of December 31, 2020 related to the classification between receivables from clients, unbilled services, and deferred revenues. The Consolidated Balance Sheet as of December 31, 2020 presented herein has been revised to reflect the correction of this error. The results of this correction on the Consolidated Balance Sheet were a decrease in unbilled services of $7.2 million, an increase in receivables from clients of $0.7 million, and a decrease in deferred revenues of $6.5 million. This error had no impact on our Consolidated Statement of Operations and Other Comprehensive Income. This error had no impact on our Consolidated Statement of Cash Flows for the three months ended March 31, 2021 and 2020. The Company evaluated the materiality of this error from both quantitative and qualitative perspectives and concluded that the impact of the error was not material to the financial statements for the year ended December 31, 2020.

Preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and related disclosures. The business and economic uncertainty resulting from the coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to predict. Accordingly, actual results and outcomes could differ from those estimates.

3. New Accounting Pronouncements

Recently Adopted

In ~~June 2016,~~October 2020, the ~~Financial Accounting Standards Board ("FASB")~~FASB issued ASU ~~2016-13,~~2020-10, ~~Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments~~ Codification Improvements.which provides a new current expected credit loss model to account for credit losses on certain financial assets, including trade receivables. That model requires an entity to estimate lifetime credit losses based on relevant historical information, adjusted for current conditions and reasonable and supportable forecasts that could affect ASU 2020-10 situates all disclosure guidance within the ~~collectability~~appropriate disclosure section of the ~~reported amount. The ASU also~~Codification and makes ~~targeted amendments~~other improvements and technical corrections to the current impairment model for available-for-sale debt securities, which includes requiring the recognition of an allowance rather than a direct write-down of the investment, which may be reversed in the event that the credit of an issuer improves.Codification. We adopted ASU ~~2016-13~~2020-10 effective January 1, ~~2020,~~2021, which did not have ~~a material~~any impact on our consolidated financial statements.

~~In August 2018, the FASB issued ASU 2018-13,~~ ~~Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement,~~ which modifies certain disclosure requirements related to fair value measurements. We adopted ASU 2018-13 effective January 1, 2020, which had no impact on the amounts reported on our consolidated financial statements. We updated our disclosures within the notes to our consolidated financial statements as required by ASU 2018-13.

~~In December 2019, the FASB issued ASU 2019-12,~~ ~~Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.~~ ~~ASU 2019-12 simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in ASC 740,~~ ~~Income Taxes~~, related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies other aspects of the accounting for franchise taxes and enacted changes in tax laws or tax rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. On January 1, 2020, we elected to early adopt ASU 2019-12 on a modified retrospective basis for those amendments that are not applied on a prospective basis. The adoption of ASU 2019-12 did not have a material impact on our consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

4. Goodwill and Intangible Assets

The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the three months ended March 31, ~~2020.~~2021.


	Healthcare		Business Advisory		Education		Total
Balance as of December 31, 2020:
Goodwill	$	636,810	$	308,935	$	104,384	$	1,050,129
Accumulated impairment losses	(208,081)		(247,811)		0		(455,892)
Goodwill, net as of December 31, 2020	428,729		61,124		104,384		594,237
Goodwill recorded in connection with a business acquisition (1)	0		3,315		0		3,315


Goodwill, net as of March 31, 2021	$	428,729	$	64,439	$	104,384	$	597,552

(1)

Healthcare

Business
Advisory
Education Total
Balance as of December 31, 2019:
Goodwill $ 636,810
$ 302,057
$ 103,889
$ 1,042,756
Accumulated impairment losses (208,081 ) (187,995 ) —
(396,076 )
Goodwill, net as of December 31, 2019 428,729
114,062
103,889
646,680
Goodwill impairment charges —
(59,816 ) —
(59,816 )
Foreign currency translation —
(629 ) —
(629 )
Goodwill, net as of March 31, 2020 $ 428,729
$ 53,617
$ 103,889
$ 586,235

On February 1, 2021, we completed the acquisition of Unico Solution, a data strategy and technology consulting firm focused on helping clients use their data to speed business transformation and accelerate cloud adoption. The results of operations of Unico Solution are included in our consolidated financial statements and results of operations of our Business Advisory segment from the date of acquisition. This acquisition is not significant to our consolidated financial statements.

First Quarter 2020 Goodwill Impairment Charges

The worldwide spread of ~~coronavirus (COVID-19)~~the COVID-19 pandemic in the first quarter of 2020 has created significant volatility, uncertainty and disruption to

the global economy. ~~We are closely monitoring~~From the ~~impact~~onset of the COVID-19 pandemic, we closely monitored the impact it could have on all aspects of our

business, including how we expect it ~~will~~to negatively impact our clients, employees and business partners. While the COVID-19 pandemic did

not have a significant impact on our consolidated revenues in the first quarter of 2020, we ~~expect~~expected it to have an unfavorable impact on

sales, increase uncertainty in the backlog and ~~business development activities and~~negatively impact full year 2020 results. ~~Additionally, we expect a decrease in the demand for the services we provide that may be considered by our clients to be more discretionary in nature.~~ The services provided by our Strategy and Innovation

and Life Sciences reporting units within our Business Advisory segment focus on strategic solutions for healthy, well-capitalized companies to

identify new growth opportunities, ~~and~~which may be considered by our clients to be more discretionary in ~~nature; therefore,~~nature, and the duration of the projects

within these practices are typically short-term. Therefore, at the onset of the COVID-19 pandemic in the U.S. and due to the uncertainty

caused by the pandemic, we ~~are~~were cautious about near-term results for these two reporting units. Based on our internal projections and the

preparation of our financial statements for the quarter ended March 31, 2020, and considering the expected decrease in demand due to the

COVID-19 pandemic, during the first quarter of 2020 we believed it was more likely than not that the fair value of these two reporting units ~~may~~ no

longer ~~exceed~~exceeded their carrying values and performed an interim impairment test on both reporting ~~units.~~units as of March 31, 2020.

Our goodwill impairment test was performed by comparing the fair value of each of the Strategy and Innovation and Life Sciences reporting units with their respective carrying values and recognizing an impairment charge for the amount by which the carrying value exceeded the fair value. To estimate the fair value of each reporting unit, we relied on a combination of the income approach and the market approach, utilizing the guideline company method, with a fifty-fifty weighting. Based on the estimated fair values of the Strategy and Innovation and Life Sciences reporting units, ~~described below,~~ we recorded non-cash pretax goodwill impairment charges of $49.9 million and $9.9 million, respectively, in the first quarter of 2020. The $49.9 million non-cash pretax charge related to the Strategy and Innovation reporting unit reduced the goodwill balance of the reporting unit to $37.5 million. The $9.9 million non-cash pretax charge related to the Life Sciences reporting unit reduced the goodwill balance of the reporting unit to ~~zero.~~0.

~~Concurrently with the~~Our goodwill impairment ~~tests~~test was performed ~~over~~by comparing the fair value of each of the Strategy and Innovation and Life Sciences reporting

units with its respective carrying value and recognizing an impairment charge for the amount by which the carrying value exceeded the fair value. To estimate the fair value of each reporting unit, we relied on a combination of the income approach and the market approach with a

fifty-fifty weighting.

In the income approach, we utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be

generated by each reporting unit and then discounting those cash flows to present value, reflecting the relevant risks associated with each

reporting unit and the time value of money. This approach requires the use of significant estimates and assumptions, including forecasted

revenue growth rates, forecasted EBITDA margins, and discount rates that reflect the risk inherent in the future cash flows. In estimating

future cash flows, we relied on internally generated seven-year forecasts. Our forecasts are based on historical experience, current backlog,

expected market demand, and other industry information.

In the market approach, we utilized the guideline company method, which involved calculating revenue multiples based on operating data

from guideline publicly traded companies. Multiples derived from guideline companies provide an indication of how much a knowledgeable

investor in the marketplace would be willing to pay for a company. These multiples were evaluated and adjusted based on specific

characteristics of the Strategy and Innovation and Life Sciences reporting units we evaluated whether any indicators exist that would lead us to believe that the fair values of our Healthcare, Education, and Business Advisory reporting units may not exceed their carrying values. Based on our internal projections, consideration of the impact of the COVID-19 pandemic on these reporting units, and review of the amounts by which the fair values of these reporting units exceeded their carrying values in the most recent quantitative goodwill impairment analysis performed, we did not identify any indicators that would lead us to believe that the fair values of these reporting units may not exceed their carrying values as of March 31, 2020.

~~In connection with the goodwill impairment tests performed on the Strategy and Innovation and Life Sciences reporting units, we performed impairment tests on the long-lived assets allocated~~relative to the ~~asset groups of the Strategy~~selected guideline companies and ~~Innovation and Life Sciences reporting units. Based on the impairment tests performed, we concluded that the long-lived assets allocated~~applied to the asset groups were not impaired as of March 31, 2020. We did not identify any indicators that would lead us to believe that the carrying values of the long-lived assets allocated to our other asset groups may not be recoverable as of March 31, 2020.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

the reporting units' operating data to arrive at an indication of value.

Intangible Assets

Intangible assets as of March 31, ~~2020~~2021 and December 31, ~~2019~~2020 consisted of the following:

As of March 31, 2020 As of December 31, 2019

Useful Life
(in years)

Gross
Carrying
Amount

Accumulated
Amortization

Gross
Carrying
Amount

Accumulated
Amortization
Customer relationships 3 to 13 $ 87,379
$ 64,265
$ 87,577
$ 61,882
Trade names 5 to 6 28,930
26,192
28,930
25,894
Technology and software 5 5,440
4,456
5,694
4,321
Non-competition agreements 5 2,220
1,559
2,220
1,447
Customer contracts 2 800
170
800
52
Total $ 124,769
$ 96,642
$ 125,221
$ 93,596


		As of March 31, 2021				As of December 31, 2020
	Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	3 to 13	$	77,030	$	58,574	$	73,629	$	56,232
Trade names	6	6,000		4,406		6,130		4,287
Non-competition agreements	5	2,210		1,560		2,090		1,541
Technology and software	5	5,800		5,474		5,800		5,380
Customer contracts	2	800		594		800		526
Total		$	91,840	$	70,608	$	88,449	$	67,966

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Customer relationships and customer contracts, as well as certain trade names and technology and software, are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the assets. All other intangible assets with finite lives are amortized on a straight-line basis.

Intangible asset amortization expense was ~~$3.2~~$2.4 million and ~~$4.5~~$3.2 million for the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, respectively. The table below sets forth the estimated annual amortization expense for the intangible assets recorded as of March 31, ~~2020.~~2021.


Year Ending December 31,	Estimated Amortization Expense		Year Ending December 31,	Estimated Amortization Expense
2020	$	12,561
2021	$	8,358	2021	$	9,059
2022	$	6,111	2022	$	6,878
2023	$	3,512	2023	$	4,231
2024	$	741	2024	$	1,384
2025			2025	$	566

Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.

5. Revenues

For the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, we recognized revenues of $203.2 million and $222.6 million, respectively. Of the $203.2 million recognized in the first quarter of 2021, we recognized revenues of $4.8 million from obligations satisfied, or partially satisfied, in prior periods, of which $2.5 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments and ~~$204.4~~$2.3 million ~~respectively.~~was due to changes in the estimates of our variable consideration under performance-based billing arrangements. Of the $222.6 million recognized in the first quarter of 2020, we recognized revenues of $7.9 million from obligations satisfied, or partially satisfied, in prior periods, of which $4.8 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $3.1 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments. Of the $204.4 million recognized in the first quarter of 2019, we recognized revenues of $3.9 million from obligations satisfied, or partially satisfied, in prior periods, due to the release of allowances on unbilled services due to securing contract amendments. During the first quarter of 2019, we recognized a $1.2 million decrease to revenues due to changes in the estimates of our variable consideration under performance-based billing arrangements.

As of March 31, ~~2020,~~2021, we had ~~$92.5~~$61.0 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude obligations under contracts with an original expected duration of one year or less, variable consideration which has been excluded from the total transaction price due to the constraint, and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the ~~$92.5~~$61.0 million of performance obligations, we expect to recognize approximately ~~$49.6~~$34.8 million as revenue in ~~2020, $28.2~~2021, $13.9 million in ~~2021,~~2022, and the remaining ~~$14.7~~$12.3 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Contract Assets and Liabilities

The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance as of March 31, ~~2020~~2021 and December 31, ~~2019~~2020 was ~~$12.4~~$16.7 million and ~~$12.6~~$17.3 million, respectively. The ~~$0.2~~$0.6 million decrease primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.

Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition policy. Our deferred revenues balance as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, was ~~$30.0~~$18.7 million and ~~$28.4~~$28.2 million, respectively. The ~~$1.6~~$9.5 million ~~increase~~decrease primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three months ended March 31, ~~2020, $14.4~~2021, $20.8 million of revenues recognized were included in the deferred revenue balance as of December 31, ~~2019.~~2020.

6. Earnings Per Share

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, unvested restricted stock units, outstanding common stock options, convertible senior notes, and outstanding warrants, to the extent dilutive. In periods for which we report a net loss from continuing operations, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss from continuing operations per share would be anti-dilutive.

Earnings (loss) per share under the basic and diluted computations are as follows:

Three Months Ended
March 31,
2020 2019
Net income (loss) from continuing operations $ (42,273 ) $ 3,350
Income (loss) from discontinued operations, net of tax (35 ) (46 )
Net income (loss) $ (42,308 ) $ 3,304

Weighted average common shares outstanding – basic 21,827
21,868
Weighted average common stock equivalents —
443
Weighted average common shares outstanding – diluted 21,827
22,311

Net earnings (loss) per basic share:
Net income (loss) from continuing operations $ (1.94 ) $ 0.15
Income (loss) from discontinued operations, net of tax —
—
Net income (loss) $ (1.94 ) $ 0.15

Net earnings (loss) per diluted share:
Net income (loss) from continuing operations $ (1.94 ) $ 0.15
Income (loss) from discontinued operations, net of tax —
—
Net income (loss) $ (1.94 ) $ 0.15


	Three Months Ended March 31,
		2021		2020
Net income (loss) from continuing operations		$	5,405	$	(42,273)
Loss from discontinued operations, net of tax		0		(35)
Net income (loss)		$	5,405	$	(42,308)

Weighted average common shares outstanding – basic		21,932		21,827
Weighted average common stock equivalents		409		0
Weighted average common shares outstanding – diluted		22,341		21,827

Net earnings (loss) per basic share:
Net income (loss) from continuing operations		$	0.25	$	(1.94)
Loss from discontinued operations, net of tax		0		0
Net income (loss)		$	0.25	$	(1.94)

Net earnings (loss) per diluted share:
Net income (loss) from continuing operations		$	0.24	$	(1.94)
Loss from discontinued operations, net of tax		0		0
Net income (loss)		$	0.24	$	(1.94)

The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above were as follows:

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

~~The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above were as follows:~~

As of March 31,
2020 2019
Unvested restricted stock awards 992
12
Outstanding common stock options 86
—
Convertible senior notes —
3,129
Warrants related to the issuance of convertible senior notes 3,129
3,129
Total anti-dilutive securities 4,207
6,270


	As of March 31,
	2021	2020
Unvested restricted stock awards	21	992
Outstanding common stock options	59	86
Warrants related to the issuance of convertible senior notes	0	3,129
Total anti-dilutive securities	80	4,207

See Note 7 “Financing Arrangements” for further information on the convertible senior notes and warrants related to the issuance of convertible notes.

~~We currently have~~In November 2020, our board of directors authorized a share repurchase program (the “2020 Share Repurchase Program”) permitting us to

repurchase up to $50 million of our common stock through December 31, 2021. The 2020 Share Repurchase Program was authorized

subsequent to the expiration of our prior share repurchase program (the “2015 Share Repurchase Program”) on October 31, 2020. The 2015

Share Repurchase Program permitted us to repurchase up to $125 million of our common stock through October 31, ~~2020 (the “Share Repurchase Program”).~~2020. The amount and

timing of ~~the~~ repurchases under both share repurchase programs were and will continue to be determined by management and ~~will~~ depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. In

Under the ~~first quarter of~~ 2020 Share Repurchase Program, we repurchased and retired ~~313,998~~245,718 shares for ~~$20.9 million. The 313,998 shares repurchased and retired~~$13.2 million in the first quarter of ~~2020~~2021 of which $1.7 million settled in the second quarter of 2021. The 245,718 shares repurchased and retired were ~~included~~reflected as a reduction to our basic weighted average shares outstanding for the quarter ended March 31, ~~2020~~2021 based on the trade date of the share repurchase. Additionally, in the first quarter of 2020, we settled the repurchase of 18,000 shares for $1.2 million that were accrued as of December 31, 2019. These shares were reflected as a reduction to our basic weighted average shares outstanding in the fourth quarter of 2019 based on the trade date of the share repurchase. No shares were repurchased during the first three months of 2019. As of March 31, ~~2020, less than $0.1~~2021, $31.8 million ~~remains~~remained available for share repurchases.

7. Financing Arrangements

A summary of the carrying amounts of our debt follows:

March 31, 2020 December 31, 2019
Senior secured credit facility $ 448,000
$ 205,000
Promissory note due 2024 3,722
3,853
Total long-term debt $ 451,722
$ 208,853
Current maturities of long-term debt (533 ) (529 )
Long-term debt, net of current portion $ 451,189
$ 208,324


	March 31, 2021		December 31, 2020
Senior secured credit facility	$	265,000	$	200,000
Promissory note due 2024	3,190		3,279
Total long-term debt	$	268,190	$	203,279
Current maturities of long-term debt	(548)		(499)
Long-term debt, net of current portion	$	267,642	$	202,780

Below is a summary of the scheduled remaining principal payments of our debt as of March 31, ~~2020.~~

Principal Payments of Long-Term Debt
2020 $ 398
2021 $ 544
2022 $ 559
2023 $ 575
2024 $ 449,646

2021.

~~Convertible Notes~~

In September 2014, the Company issued $250 million principal amount of 1.25% convertible senior notes due 2019 (the “Convertible Notes”) in a private offering. The Convertible Notes were governed by the terms of an indenture between the Company and U.S. Bank National Association, as Trustee (the “Indenture”). The Convertible Notes were senior unsecured obligations of the Company and paid interest semi-annually on April 1 and October 1 of each year at an annual rate of 1.25%.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

Prior to maturity, upon conversion, the Convertible Notes would have been settled, at our election, in cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock. Our intent and policy was to settle conversions with a combination of cash and shares of common stock with the principal amount of the Convertible Notes paid in cash, in accordance with the settlement provisions of the Indenture.

Upon issuance, we separated the Convertible Notes into liability and equity components. The carrying value of the equity component representing the conversion option, which was recognized as a debt discount, was determined by deducting the fair value of the liability component from the proceeds of the Convertible Notes. The debt discount was amortized to interest expense using an effective interest rate of 4.751% over the term of the Convertible Notes. The equity component was not remeasured as it continued to meet the conditions for equity classification.

The transaction costs related to the issuance of the Convertible Notes were separated into liability and equity components based on their relative values. Transaction costs attributable to the liability component were recorded as a deduction to the carrying amount of the liability and amortized to interest expense over the term of the Convertible Notes; and transaction costs attributable to the equity component were netted with the equity component of the Convertible Notes in stockholders’ equity.

~~The following table presents the amount of interest expense recognized related to the Convertible Notes for the period presented.~~

Three Months Ended
March 31, 2019
Contractual interest coupon $ 781
Amortization of debt discount 2,120
Amortization of debt issuance costs 315
Total interest expense $ 3,216

In connection with the issuance of the Convertible Notes, we entered into convertible note hedge transactions and warrant transactions. The convertible note hedge transactions were intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raised the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. The convertible note hedge transactions expired in the third quarter of 2019. The holders of the warrants have the option to purchase an initial total of approximately 3.1 million shares of the Company’s common stock at a strike price of approximately $97.12. The warrants are expiring incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date. If the average market value per share of our common stock for the reporting period exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share. The warrants are separate transactions and are not part of the terms of the Convertible Notes or the convertible note hedge transactions.


	Principal Payments of Long-Term Debt
2021	$	410
2022	$	559
2023	$	575
2024	$	266,646

Senior Secured Credit Facility

The Company has a $600 million senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on September 27, ~~2024~~.2024. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $750 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.

Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.125% per annum and 1.875% per annum, in the case of LIBOR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including upon an Event of Default (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

The loans and obligations under the Amended Credit Agreement are secured pursuant to a Second Amended and Restated Security Agreement and a Second Amended and Restated Pledge Agreement ~~(as amended, the~~(the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement).

Borrowings outstanding under the Amended Credit Agreement at March 31, ~~2020~~2021 totaled ~~$448.0~~$265.0 million. These borrowings carried a weighted average interest rate of ~~2.3%~~2.4%, including the effect of the interest rate swaps described in Note 9 “Derivative Instruments and Hedging Activity." Borrowings outstanding under the Amended Credit Agreement at December 31, ~~2019~~2020 were ~~$205.0~~$200.0 million and carried a weighted average interest rate of ~~3.0%~~2.5%, including the effect of the interest rate ~~swap~~swaps outstanding at the time and described in Note 9 “Derivative Instruments and Hedging Activity." The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At March 31, ~~2020,~~2021, we had outstanding letters of credit totaling ~~$1.6~~$0.8 million, which are primarily used as security deposits for our office facilities. As of March 31, ~~2020,~~2021, the unused borrowing capacity under the revolving credit facility was ~~$150.4~~$334.2 million.

Promissory Note due 2024

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024,, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we ~~will~~ pay interest on the outstanding principal amount at a rate of one month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At March 31, 2021, the outstanding principal amount of the promissory note was $3.2 million, and the aircraft had a carrying amount of $4.3 million. At December 31, 2020, the outstanding principal amount of the promissory note was ~~$3.7~~$3.3 million, and the aircraft had a carrying amount of ~~$4.9~~$4.4 million. ~~At December 31, 2019, the outstanding principal amount~~

Table of ~~the promissory note was $3.9 million, and the aircraft had a carrying amount of $5.1 million.~~Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

8. Restructuring Charges

Restructuring charges for the ~~first~~ three months ~~of 2020 totaled $1.6~~ended March 31, 2021 were $0.6 million compared to ~~$1.3~~$1.6 million, for the ~~first~~ three months ended March 31, 2020.

The $0.6 million restructuring charge recognized in the first quarter of ~~2019.~~ 2021 primarily related to rent and related expenses, net of sublease income, and accelerated depreciation on furniture and fixtures for vacated office spaces.

The $1.6 million restructuring charge ~~incurred~~recognized in the first quarter of 2020 ~~related to~~included a $1.2 million accrual for the termination of a third-party advisor agreement, $0.3 million related to workforce reductions to better align resources with market demand, and $0.1 million related to workforce reductions in our corporate operations. ~~During~~

In the ~~first~~fourth quarter of ~~2019,~~2020, we ~~exited~~announced a ~~portion~~restructuring plan to reduce operating costs to address the impact of the COVID-19 pandemic on our ~~Lake Oswego, Oregon corporate~~business. The restructuring plan, which was substantially complete in the fourth quarter of 2020, provided for a reduction in certain leased office ~~resulting~~spaces and a reduction in a $0.7 million lease impairment charge on the related operating lease right-of-use asset and leasehold improvements and $0.2 million of accelerated depreciation on furniture and fixtures in that office. Additionally, we recognized a $0.2 million restructuring charge related to workforce reductions in our corporate operations.workforce.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the three months ended March 31, ~~2020.~~

2021.


													Employee Costs		Office Space Reductions		Other		Total
	Employee Costs			Office Space Reductions		Other			Total
Balance as of December 31, 2019	$	68		$	91	$	—		$	159
Balance as of December 31, 2020												Balance as of December 31, 2020	$	2,447	$	84	$	893	$	3,424
Additions	411			—		1,188			1,599			Additions	4		0		0		4
Payments	(473		)	—		(67		)	(540		)	Payments	(2,382)		(39)		(167)		(2,588)
Adjustments	8			—		—			8			Adjustments	10		0		0		10
Balance as of March 31, 2020	$	14		$	91	$	1,121		$	1,226
Balance as of March 31, 2021												Balance as of March 31, 2021	$	79	$	45	$	726	$	850

The $0.1 million restructuring charge liability related to office space reductions at March 31, 2020 is included as a component of accrued expenses and other current liabilities and deferred compensation and other liabilities. The restructuring charge liability related to employee costs at March 31, ~~2020~~2021 is expected to be paid in the next 12 months and is included as a component of accrued payroll and related benefits. The ~~$1.1 million~~employee related payments made in the first quarter of 2021 primarily related to the fourth quarter 2020 restructuring plan. The restructuring charge liability related to office space reductions at March 31, 2021 is included as a component of accrued expenses and other current liabilities. The $0.7 million other restructuring charge liability at March 31, 2021 is related to the termination of a third-party advisor agreement ~~at March 31, 2020~~and is expected to be paid over the next 3422 months and is included as a component of accrued expenses and other current liabilities and deferred compensation and other liabilities.

9. Derivative Instruments and Hedging Activity

On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022,, with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 1.900%.

On January 30, 2020, we entered into a forward interest rate swap agreement effective December 31, 2019 and ending December 31, 2024,, with a notional amount of $50.0 million. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 1.500%.

On March 16, 2020, we entered into a forward interest rate swap agreement effective February 28, 2020 and ending February 28, 2025,, with a notional amount of $100.0 million. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 0.885%.

We recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. We have designated these derivative instruments as cash flow hedges. Therefore, changes in the fair value of the derivative instruments are recorded to other comprehensive income (“OCI”) to the extent effective and reclassified into interest expense upon settlement. As of March 31, ~~2020,~~2021, it was anticipated that ~~$1.4~~$1.7 million of the losses, net of tax, currently recorded in accumulated other comprehensive income will be reclassified into earnings within the next 12 months.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth additional information relating to the interest rate swaps designated as a cash flow hedging instrument as of March 31, ~~2020~~2021 and December 31, ~~2019.~~2020.

Fair Value (Derivative Asset and Liability)
Balance Sheet Location March 31,
2020 December 31,
2019
Accrued expenses and other current liabilities $ 1,156
$ 159
Deferred compensation and other liabilities $ 1,666
$ 387


	Fair Value (Derivative Asset and Liability)
Balance Sheet Location	March 31, 2021		December 31, 2020


Accrued expenses and other current liabilities	$	2,168	$	2,100
Deferred compensation and other liabilities	$	1,260	$	3,297

All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis on our consolidated balance sheet.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

We do not use derivative instruments for trading or other speculative purposes. Refer to Note 11 “Other Comprehensive Income (Loss)” for additional information on our derivative instruments.

10. Fair Value of Financial Instruments

Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:



Level 1 Inputs						Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 Inputs						Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 Inputs						Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of March 31, ~~2020~~2021 and December 31, ~~2019.~~2020.

Level 1 Level 2 Level 3 Total
March 31, 2020
Assets:
Convertible debt investment $ —
$ —
$ 62,194
$ 62,194
Deferred compensation assets —
24,220
—
24,220
Total assets $ —
$ 24,220
$ 62,194
$ 86,414
Liabilities:
Interest rate swaps $ —
$ 2,822
$ —
$ 2,822
Total liabilities $ —
$ 2,822
$ —
$ 2,822
December 31, 2019
Assets:
Convertible debt investment —
—
49,542
49,542
Deferred compensation assets —
27,445
—
27,445
Total assets $ —
$ 27,445
$ 49,542
$ 76,987
Liabilities:
Interest rate swap $ —
$ 546
$ —
$ 546
Total liabilities $ —
$ 546
$ —
$ 546


	Level 1		Level 2		Level 3		Total
March 31, 2021
Assets:

Convertible debt investment	$	0	$	0	$	58,036	$	58,036
Deferred compensation assets	0		34,881		0		34,881
Total assets	$	0	$	34,881	$	58,036	$	92,917
Liabilities:
Interest rate swaps	$	0	$	3,428	$	0	$	3,428
Contingent consideration for business acquisition	0		0		1,812		1,812
Total liabilities	$	0	$	3,428	$	1,812	$	5,240
December 31, 2020
Assets:

Convertible debt investment	$	0	$	0	$	64,364	$	64,364
Deferred compensation assets	0		34,056		0		34,056
Total assets	$	0	$	34,056	$	64,364	$	98,420
Liabilities:
Interest rate swaps	$	0	$	5,397	$	0	$	5,397
Contingent consideration for business acquisition	0		0		1,770		$	1,770
Total liabilities	$	0	$	5,397	$	1,770	$	7,167

Interest rate swaps: The fair values of our interest rate swaps were derived using estimates to settle the interest rate swap agreements, which are based on the net present value of expected future cash flows on each leg of the swaps utilizing market-based inputs and a discount rate reflecting the risks involved.

Convertible debt investment: In 2014 and 2015, we invested $27.9 million, in the form of zero coupon convertible debt (the "initial convertible

notes"), in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight, a U.S.-based company that partners with leading nonprofit universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. In the first quarter of 2020, we invested an additional $13.0 million, in the form of 1.69% convertible debt with a

senior liquidation preference to the initial convertible notes (the "additional convertible note"); and amended our initial convertible notes to ~~include a coupon rate of 1.69% and~~

extend the maturity date to January 17, 2024,, which coincides with the maturity date of the additional convertible note.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security.

The investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive

income. We estimate the fair value of our investment using a scenario-based approach in the form of a hybrid analysis that consists of a Monte Carlo simulation model and an expected return analysis. The conclusion of value for our investment is based on the probability weighted assessment of both scenarios. The hybrid analysis utilizes certain assumptions including the assumed holding period through the maturity date of January 17, 2024,, the applicable waterfall distribution at the end of the expected holding period based on the rights and privileges of the various instruments, cash flow projections discounted at the risk-adjusted rate of ~~26%~~22.5%, and the concluded equity volatility of ~~42.5%~~45.0%, all of which are Level 3 inputs. The valuation of our investment as of December 31, 2019 takes into consideration the equity value indication as well as the dilutive impact of the convertible debt issued by Shorelight in the first quarter of 2020, the terms of which were known or knowable as of December 31, 2019. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The fair value of the convertible debt investment is recorded in long-term investments on our consolidated balance sheets.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth the changes in the balance of the convertible debt investment for the three months ended March 31, ~~2020.~~2021.

Convertible Debt Investment
Balance as of December 31, 2019 $ 49,542
Purchases 13,000
Change in fair value of convertible debt investment (348 )
Balance as of March 31, 2020 $ 62,194


	Convertible Debt Investment
Balance as of December 31, 2020	$	64,364

Change in fair value of convertible debt investment	(6,328)
Balance as of March 31, 2021	$	58,036

Deferred compensation assets: We have a non-qualified deferred compensation plan (the "Plan") for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets on our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.

Contingent consideration for business acquisition: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being measured or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and a discount rate which typically reflects a risk-free rate, and was 2.41% as of March 31, 2021 and December 31, 2020. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates.

The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the three months ended March 31, 2021.


	Contingent Consideration for Business Acquisitions
Balance as of December 31, 2020	1,770
Remeasurement of contingent consideration for business acquisitions	42
Balance as of March 31, 2021	$	1,812

Financial assets and liabilities not recorded at fair value are as follows:

Preferred Stock Investment

In the fourth quarter of 2019, we invested $5.0 million, in the form of preferred stock, in Medically Home Group, Inc. ("Medically Home"), a healthcare technology-enabled services company. To determine the appropriate accounting treatment for our investment, we performed a VIE analysis and concluded that Medically Home does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the preferred stock is not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment for our investment in Medically Home to be that of an equity security with no readily determinable fair value. We elected to apply the measurement alternative at the time of the purchase and will continue to do so until the investment does not qualify to be so measured. Under the measurement alternative, the investment is carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment in Medically Home. On a quarterly basis, we review the information available to determine whether an orderly and observable transaction for the same or similar equity instrument occurred, and remeasure the fair value of the preferred stock using such identified transactions, with changes in the fair value recorded in consolidated statement of operations. ~~Following~~As of March 31, 2021, the carrying amount of our ~~purchase, there has been no impairment, nor any observable price changes to our investment.~~preferred stock investment was $6.7 million.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Senior Secured Credit Facility

The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 7 “Financing Arrangements” for additional information on our senior secured credit facility.

Promissory Note due 2024

The carrying value of our promissory note due 2024 is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the promissory note bears interest at rates based on current market rates as set forth in the terms of the promissory note. Refer to Note 7 “Financing Arrangements” for additional information on our promissory note due 2024.

Cash and Cash Equivalents and Other Financial Instruments

Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.

11. Other Comprehensive Income (Loss)

The table below sets forth the components of other comprehensive income (loss), net of tax, for the three months ended March 31, ~~2020~~2021 and ~~2019.~~2020.


	Three Months Ended March 31, 2021						Three Months Ended March 31, 2020
	Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments	$	400	$	0	$	400	$	(779)	$	0	$	(779)
Unrealized gain (loss) on investment	$	(6,328)	$	1,680	$	(4,648)	$	(348)	$	90	$	(258)
Unrealized gain (loss) on cash flow hedges:
Change in fair value	$	1,189	$	(337)	$	852	$	(2,272)	$	590	$	(1,682)
Reclassification adjustments into earnings	780		(203)		577		(4)		1		(3)
Net unrealized gain (loss)	$	1,969	$	(540)	$	1,429	$	(2,276)	$	591	$	(1,685)
Other comprehensive income (loss)	$	(3,959)	$	1,140	$	(2,819)	$	(3,403)	$	681	$	(2,722)

Three Months Ended
March 31, 2020 Three Months Ended
March 31, 2019
Before
Taxes Tax
(Expense)
Benefit Net of
Taxes Before
Taxes Tax
(Expense)
Benefit Net of
Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments $ (779 ) $ —
$ (779 ) $ 316
$ —
$ 316
Unrealized gain (loss) on investment $ (348 ) $ 90
$ (258 ) $ 3,609
$ (952 ) $ 2,657
Unrealized gain (loss) on cash flow hedges:
Change in fair value $ (2,272 ) $ 590
$ (1,682 ) $ (247 ) $ 65
$ (182 )
Reclassification adjustments into earnings (4 ) 1
(3 ) (74 ) 19
(55 )
Net unrealized gain (loss) $ (2,276 ) $ 591
$ (1,685 ) $ (321 ) $ 84
$ (237 )
Other comprehensive income (loss) $ (3,403 ) $ 681
$ (2,722 ) $ 3,604
$ (868 ) $ 2,736

The before tax amounts reclassified from accumulated other comprehensive income related to our cash flow hedges are recorded to interest expense, net of interest income.

Accumulated other comprehensive income, net of tax, includes the following components:


	Foreign Currency Translation		Available-for-Sale Investment		Cash Flow Hedges		Total
Balance, December 31, 2020	$	(218)	$	17,205	$	(3,926)	$	13,061
Current period change	400		(4,648)		1,429		(2,819)
Balance, March 31, 2021	$	182	$	12,557	$	(2,497)	$	10,242

Foreign Currency
Translation
Available-for-Sale Investment Cash Flow Hedges Total
Balance, December 31, 2019 $ (566 ) $ 15,882
$ (380 ) $ 14,936
Current period change (779 ) (258 ) (1,685 ) (2,722 )
Balance, March 31, 2020 $ (1,345 ) $ 15,624
$ (2,065 ) $ 12,214

12. Income Taxes

OnFor the three months ended March 27, 2020, the President of the United States signed into law the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”). The CARES Act is an approximately $2 trillion emergency economic stimulus package in response to the COVID-19 outbreak, which among other items, includes31, 2021, our effective tax rate was 22.1% as we recognized income tax ~~provisions relating to net operating loss carryback periods and technical corrections to~~expense from continuing operations of $1.5 million on income from continuing operations of $6.9 million. The effective tax ~~depreciation methods for qualified improvement property. As a result~~rate of 22.1% was more favorable than the ~~enactment of this legislation during the first quarter of 2020, we recorded a tax~~

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

~~benefit~~statutory rate, inclusive of ~~$0.8 million related to the remeasurement~~state income taxes, of ~~a portion of our income tax receivable~~26.6%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the ~~ability to apply the federal net operating loss incurred in 2018 to prior year income for a refund at a higher tax rate in the carryback period.~~first quarter of 2021. This favorable item was partially offset by certain nondeductible expense items.

For the three months ended March 31, 2020, our effective tax rate was 21.0% as we recognized an income tax benefit from continuing operations of $11.2 million on a loss from continuing operations of $53.5 million. The effective tax rate of 21.0% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to certain nondeductible expense items, non-deductible losses on our investments used to fund our deferred compensation liability, and the nondeductible portion of the goodwill impairment charges recorded during the first quarter of 2020. These unfavorable items were partially offset by a discrete tax benefit for share-based compensation awards that vested during the quarter and the discrete tax benefit for the remeasurement of a portion of our income tax receivable as a result of the enactment of the Coronavirus Aid, Relief, and Economic Security Act (“CARES ~~Act~~Act”) in the first quarter of 2020.

~~For~~The CARES Act, which was signed into law on March 27, 2020, is an approximately $2 trillion emergency economic stimulus package in response to the ~~three months ended March 31, 2019, our effective~~COVID-19 outbreak, which among other items, includes income tax ~~rate was 29.0%~~provisions relating to net operating loss carryback periods and technical corrections to tax depreciation methods for qualified improvement property. During 2020, as a result of the CARES Act, we recognized a $1.5 million tax benefit related to the remeasurement of a portion of our income tax ~~expense from continuing operations of $1.4 million on~~receivable for the federal net operating loss incurred in 2018 and the expected federal net operating loss in 2020 that will be carried back to prior year income, ~~from continuing operations of $4.7 million. The effective~~both for a refund at the higher, prior year tax rate of 29.0% was less favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to foreign losses with no tax benefit and disallowed executive compensation deductions. These unfavorable items were partially offset by a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2019.rate.

13. Commitments, Contingencies and Guarantees

Litigation

Oaktree

On November 9, 2018, Huron was engaged by Oaktree Medical Centre LLC, a management services organization (“Oaktree”) to perform interim management and financial advisory services. As part of the services, a Huron employee was appointed by Oaktree’s board of directors to serve as Chief Restructuring Officer of Oaktree. The engagement letter through which Oaktree retained Huron’s services states that all disputes or claims are subject to binding arbitration, disclaims special, consequential, incidental or exemplary damages or loss and caps liability to the fees paid for the portion of the engagement giving rise to any liability. On September 19, 2019, Oaktree filed for Chapter 7 liquidation in the U.S. Bankruptcy Court for the Western District of North Carolina, with the case subsequently transferred to the District of South Carolina. As a result of the bankruptcy filing, a Chapter 7 trustee was appointed to oversee the bankruptcy estate, at which time Huron’s services for Oaktree wound down.

In April 2021, Trustee’s counsel communicated in writing to Huron its intent to pursue various claims against Huron, among others, on behalf of the bankruptcy estate related to the services carried out by Huron during the engagement. The allegations suggest that Huron did not develop and implement a Chapter 11 restructuring plan on a timely basis and that its failure to do so led to significant damages. We believe the Trustee’s allegations with respect to Huron are without merit and will vigorously defend ourselves should any claim arising out of these alleged facts and circumstances be asserted against us by the Trustee.

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

Guarantees

Guarantees in the form of letters of credit totaling ~~$1.6~~$0.8 million and ~~$1.7~~$1.6 million were outstanding at March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively, primarily to support certain office lease obligations.

In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, the total estimated fair value of our outstanding contingent consideration liability was ~~zero.~~$1.8 million.

To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

14. Segment Information

Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our chief executive officer, manages the business under 3 operating segments, which are our reportable segments: Healthcare, Business Advisory, and Education.

•Healthcare

Our Healthcare segment ~~has a depth of expertise in financial and operational improvement, care transformation, culture and organizational excellence, strategy, and technology and analytics. We serve~~serves national and regional hospitals, integrated health systems, academic medical centers, community hospitals, and medical groups. Our Healthcare professionals have a depth of expertise in business operations, including financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions. Most healthcare organizations are focused on changing the way care is delivered; establishing a sustainable business model centered around optimal cost structures, reimbursement models and financial strategies; and evolving their digital, technology and analytic capabilities. Our solutions help clients ~~evolve and~~ adapt to ~~the~~this rapidly changing healthcare environment to become a more agile, efficient and ~~achieve growth, optimize~~consumer-centric organization. We use our deep industry expertise to help clients solve a diverse set of business issues, including, but not limited to, optimizing financial and operational performance, ~~enhance profitability, improve quality~~improving care delivery and clinical outcomes, ~~align leaders, improve organizational culture, and drive~~increasing physician, patient and employee ~~engagement across the enterprise to deliver better consumer outcomes.~~ satisfaction, evolving organizational culture, and maximizing return on technology investments.

•Business Advisory

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

We help organizations transform and innovate their delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health. Our consultants partner with clients to help build and sustain today’s business to invest in the future by reducing complexity, improving operational efficiency and growing market share. We enable the healthcare of the future by identifying, integrating and optimizing technology investments to collect data that transforms care delivery and improves patient outcomes. We also develop future leaders capable of driving meaningful cultural and organizational change and who transform the consumer experience.

~~Business Advisory~~

Our Business Advisory segment ~~provides services to large~~works with C-suite executives, boards, and ~~middle market~~business unit and functional leadership across a diverse set of organizations, ~~lending institutions, law firms, investment banks, private equity firms, and not-for-profit organizations,~~ including ~~higher education and healthcare institutions. We assist clients in a broad range of industries and across the spectrum from~~ healthy, well-capitalized companies to organizations in transition, ~~as well as creditors, equity owners,~~ and ~~other key constituents. Our Enterprise Solutions~~across a broad range of industries, including life sciences, financial services, healthcare, education, energy and ~~Analytics experts advise, deliver,~~utilities, industrials and ~~optimize technology~~manufacturing, and ~~analytic solutions that enable organizations to manage and optimize their financial performance, operational efficiency, and client or stakeholder experience.~~the public sector. Our Business Advisory professionals have deep industry, functional and technical expertise that they put forward when delivering our digital, technology and analytics, strategy and innovation and corporate finance and restructuring services. In today’s disruptive environment, organizations must reimagine their historical strategies and financial and operating models to sustain and advance their competitive advantage. Organizations also recognize the need to adopt technologies, automation and analytics to improve their operations and compete in a rapidly changing environment. Our experts ~~resolve complex~~help organizations across industries with a variety of business ~~issues~~challenges, including, but not limited to, embedding technology and ~~enhance client~~analytics throughout their internal and customer-facing operations, developing insights into the needs of tomorrow’s customers in order to evolve their enterprise ~~value~~and business unit strategies, bringing new products to market, and managing through stressed and distressed situations to create a suite of services including capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory. Our Strategy and Innovation professionals collaborate with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Our Life Sciences professionals provideviable path forward for stakeholders.

•Education~~strategic solutions to help pharmaceutical, medical device, and biotechnology companies deliver more value to patients, payers, and providers, and comply with regulations.~~

~~Education~~

Our Education segment ~~provides consulting~~serves public and ~~technology solutions to higher education institutions~~private colleges and universities, academic medical ~~centers.~~centers, research institutes and other not-for-profit organizations. Our Education professionals have a depth of expertise in strategy and innovation; business operations, including the research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation. Our Education segment clients are increasingly faced with financial and/or demographic challenges as well as increased competition. To remain competitive, organizations must challenge traditional operating and financial models and reimagine strategic, operational and research-centered opportunities that advance their mission while strengthening their business models. We collaborate with clients to address these challenges ~~relating~~and ensure they have a sustainable future. We combine our deep industry, functional and technical expertise to help clients solve their most pressing challenges, including, but not limited to, transforming business operations with technology; strengthening research strategies and ~~technology strategy,~~support services; evolving their organizational strategy; optimizing financial and operational ~~excellence, student success, research administration,~~performance; and regulatory compliance. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance. Our technology strategy, enterprise applications, and analytic solutions transform and optimize operations, deliver time and cost savings, and enhanceenhancing the student experience. Our institutional strategy, budgeting and financial management, and business operations align missions with business priorities, improve quality, and reduce costs institution-wide. Our student solutions improve attraction, retention and graduation rates, increase student satisfaction and help generate quality outcomes.lifecycle.

Segment operating income consists of the revenues generated by a segment, less the direct costs of revenue and selling, general and administrative expenses that are incurred directly by the segment. Unallocated corporate costs include costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include costs for corporate office support, certain office facility costs, costs relating to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth information about our operating segments for the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.


	Three Months Ended March 31,							Three Months Ended March 31,
	2020			2019					2021			2020
Healthcare:							Healthcare:
Revenues	$	95,578		$	93,682		Revenues		$	79,722		$	95,578
Operating income	$	24,050		$	27,851		Operating income		$	20,484		$	24,050
Segment operating income as a percentage of segment revenues	25.2		%	29.7		%	Segment operating income as a percentage of segment revenues		25.7		%	25.2		%
Business Advisory:							Business Advisory:
Revenues	$	64,905		$	58,806		Revenues		$	72,867		$	64,905
Operating income	$	9,842		$	9,581		Operating income		$	13,077		$	9,842
Segment operating income as a percentage of segment revenues	15.2		%	16.3		%	Segment operating income as a percentage of segment revenues		17.9		%	15.2		%
Education:							Education:
Revenues	$	62,136		$	51,957		Revenues		$	50,624		$	62,136
Operating income	$	13,116		$	12,618		Operating income		$	8,653		$	13,116
Segment operating income as a percentage of segment revenues	21.1		%	24.3		%	Segment operating income as a percentage of segment revenues		17.1		%	21.1		%
Total Company:							Total Company:
Revenues	$	222,619		$	204,445		Revenues		$	203,213		$	222,619
Reimbursable expenses	19,303			18,617			Reimbursable expenses		1,934			19,303
Total revenues and reimbursable expenses	$	241,922		$	223,062		Total revenues and reimbursable expenses		$	205,147		$	241,922

Segment operating income	$	47,008		$	50,050		Segment operating income		$	42,214		$	47,008
Items not allocated at the segment level:							Items not allocated at the segment level:
Other operating expenses	27,146			36,578			Other operating expenses		28,837			27,146
Litigation and other gains	(150		)	(456		)	Litigation and other gains		42			(150)
Depreciation and amortization	6,047			7,172			Depreciation and amortization		5,095			6,047
Goodwill impairment charges¹	59,816			—			Goodwill impairment charges1		0			59,816
Other expense, net	7,637			2,041			Other expense, net		1,299			7,637
Income (loss) from continuing operations before taxes	$	(53,488	)	$	4,715		Income (loss) from continuing operations before taxes		$	6,941		$	(53,488)

(1) The non-cash goodwill impairment charges are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance.


~~(1)~~	The goodwill impairment charges are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The following table illustrates the disaggregation of revenues by billing arrangements, employee types, and timing of revenue recognition, including a reconciliation of the disaggregated revenues to revenues from our ~~three~~3 operating segments for the three months ended March 31, ~~2020~~2021 and ~~2019.~~

2020.


	Three Months Ended March 31, 2020									Three Months Ended March 31, 2021
	Healthcare		Business Advisory		Education		Total			Healthcare		Business Advisory		Education		Total
Billing Arrangements									Billing Arrangements
Fixed-fee	$	55,785	$	25,393	$	13,175	$	94,353	Fixed-fee	$	48,295	$	29,881	$	15,259	$	93,435
Time and expense	14,733		37,589		43,711		96,033		Time and expense	11,375		37,633		28,784		77,792
Performance-based	18,921		646		—		19,567		Performance-based	14,669		3,409		0		18,078
Software support, maintenance and subscriptions	6,139		1,277		5,250		12,666		Software support, maintenance and subscriptions	5,383		1,944		6,581		13,908
Total	$	95,578	$	64,905	$	62,136	$	222,619	Total	$	79,722	$	72,867	$	50,624	$	203,213

Employee Type ⁽¹⁾									Employee Type (1)
Revenue generated by full-time billable consultants	$	65,445	$	61,957	$	53,436	$	180,838
Revenue generated by billable consultants									Revenue generated by billable consultants	$	59,569	$	69,847	$	42,528	$	171,944
Revenue generated by full-time equivalents	30,133		2,948		8,700		41,781		Revenue generated by full-time equivalents	20,153		3,020		8,096		31,269
Total	$	95,578	$	64,905	$	62,136	$	222,619	Total	$	79,722	$	72,867	$	50,624	$	203,213

Timing of Revenue Recognition									Timing of Revenue Recognition
Revenue recognized over time	$	94,459	$	64,905	$	62,022	$	221,386	Revenue recognized over time	$	78,764	$	72,867	$	50,624	$	202,255
Revenue recognized at a point in time	1,119		—		114		1,233		Revenue recognized at a point in time	958		0		0		958
Total	$	95,578	$	64,905	$	62,136	$	222,619	Total	$	79,722	$	72,867	$	50,624	$	203,213

Three Months Ended March 31, 2019
Healthcare Business Advisory Education Total
Billing Arrangements
Fixed-fee $ 63,584
$ 21,672
$ 12,383
$ 97,639
Time and expense 12,763
35,309
35,358
83,430
Performance-based 11,810
664
—
12,474
Software support, maintenance and subscriptions 5,525
1,161
4,216
10,902
Total $ 93,682
$ 58,806
$ 51,957
$ 204,445

Employee Type ⁽¹⁾

Revenue generated by full-time billable consultants $ 64,818
$ 57,094
$ 46,007
$ 167,919
Revenue generated by full-time equivalents 28,864
1,712
5,950
36,526
Total $ 93,682
$ 58,806
$ 51,957
$ 204,445

Timing of Revenue Recognition
Revenue recognized over time $ 91,642
$ 58,806
$ 51,711
$ 202,159
Revenue recognized at a point in time 2,040
—
246
2,286
Total $ 93,682
$ 58,806
$ 51,957
$ 204,445

~~(1)~~

Full-time billable consultants consist of our full-time professionals who provide consulting services to our clients and are billable to our clients based on the number of hours worked. Full-time equivalent professionals consist of leadership coaches and their support staff within our Healthcare Leadership solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.


	Three Months Ended March 31, 2020
	Healthcare		Business Advisory		Education		Total
Billing Arrangements
Fixed-fee	$	55,785	$	25,393	$	13,175	$	94,353
Time and expense	14,733		37,589		43,711		96,033
Performance-based	18,921		646		0		19,567
Software support, maintenance and subscriptions	6,139		1,277		5,250		12,666
Total	$	95,578	$	64,905	$	62,136	$	222,619

Employee Type (1)
Revenue generated by billable consultants	$	65,445	$	61,957	$	53,436	$	180,838
Revenue generated by full-time equivalents	30,133		2,948		8,700		41,781
Total	$	95,578	$	64,905	$	62,136	$	222,619

Timing of Revenue Recognition
Revenue recognized over time	$	94,459	$	64,905	$	62,022	$	221,386
Revenue recognized at a point in time	1,119		0		114		1,233
Total	$	95,578	$	64,905	$	62,136	$	222,619

(1) Billable consultants consist of our consulting professionals who provide consulting services to our clients and are billable to our clients based on the number of hours worked. Full-time equivalent professionals consist of leadership coaches and their support staff within our Culture and Organizational Excellence solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.

At March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, no single client accounted for greater than 10% of our combined balance of receivables from

clients, net and unbilled services, net. During the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, no single client generated greater than 10% of our consolidated revenues.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

15. Subsequent Event

Healthcare Group Hiring

On April 5, 2021, we hired approximately 300 full-time equivalent professionals within our Healthcare operating segment. These additional professionals will expand our capacity to provide revenue cycle billing, collections, insurance verification and charge integrity services to our healthcare clients. These professionals will serve new and existing clients in our Healthcare managed services solution, including serving under a short-term contract with an existing client which we entered into in connection with this group hire. The hiring of these professionals is not significant to our consolidated financial statements.

Table of Contents



ITEM 2.			MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Huron,” “Company,” “we,” “us” and “our” refer to Huron Consulting Group Inc. and its subsidiaries.

Statements in this Quarterly Report on Form 10-Q that are not historical in nature, including those concerning the Company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “guidance,” or “outlook,” or similar expressions. These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: the impact of the COVID-19 pandemic on the economy, our clients and client demand for our services, and our ability to sell and provide services, including the measures taken by governmental authorities and businesses in response to the pandemic, which may cause or contribute to other risks and uncertainties that we face; failure to achieve expected utilization rates, billing rates, and the number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under Item 1A. “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, ~~2019 and under Part II, Item 1A. "Risk Factors" in this Quarterly Report on Form 10-Q,~~2020 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

OVERVIEW

Our Business

Huron is a global consultancy that collaborates with clients to drive strategic growth, ignite innovation and navigate constant change. Through a combination of strategy, expertise and creativity, we help clients accelerate operational, digital and cultural transformation, enabling the change they need to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve.

We provide professional services through three operating segments: Healthcare, Business Advisory, and Education.

•Healthcare

Business Advisory

Table of Contents

•Education

Our Education segment serves public and private colleges and universities, academic medical centers, research institutes and other not-for-profit organizations. Our Education professionals have a depth of expertise in strategy and innovation; business operations, including the research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation. Our Education segment clients are increasingly faced with financial and/or demographic challenges as well as ~~creditors, equity owners,~~increased competition. To remain competitive, organizations must challenge traditional operating and ~~other key constituents. Our Enterprise Solutions~~financial models and ~~Analytics experts advise, deliver,~~reimagine strategic, operational and ~~optimize technology and analytic solutions~~research-centered opportunities that ~~enable organizations to manage and optimize~~advance their ~~financial performance, operational efficiency, and client or stakeholder experience. Our Business Advisory experts resolve complex~~mission while strengthening their business ~~issues and enhance client enterprise value~~

~~Table of Contents~~

through a suite of services including capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory. Our Strategy and Innovation professionals collaborate with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Our Life Sciences professionals provide~~strategic solutions to help pharmaceutical, medical device, and biotechnology companies deliver more value to patients, payers, and providers, and comply with regulations.~~

~~Education~~

~~Our Education segment provides consulting and technology solutions to higher education institutions and academic medical centers.~~models. We collaborate with clients to address these challenges ~~relating~~and ensure they have a sustainable future. We combine our deep industry, functional and technical expertise to help clients solve their most pressing challenges, including, but not limited to, transforming business operations with technology; strengthening research strategies and ~~technology strategy,~~support services; evolving their organizational strategy; optimizing financial and operational ~~excellence, student success, research administration,~~performance; and regulatory compliance. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance. Our technology strategy, enterprise applications, and analytic solutions transform and optimize operations, deliver time and cost savings, and enhanceenhancing the student experience. Our institutional strategy, budgeting and financial management, and business operations align missions with business priorities, improve quality, and reduce costs institution-wide. Our student solutions improve attraction, retention and graduation rates, increase student satisfaction and help generate quality outcomes.lifecycle.

Huron is ~~a Platinum level member of the Oracle PartnerNetwork,~~ an Oracle ~~Cloud Premier Partner within North America,~~partner, a ~~Gold level~~Gold-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org, a Workday Services ~~Partner.~~and Software Partner, an Amazon Web Services consulting partner, a Silver-level system integrator with Informatica and an SAP Concur implementation partner.

Coronavirus ~~(COVID-19)~~(COVID-19)

The worldwide spread of ~~coronavirus (COVID-19)~~COVID-19 beginning in ~~the first quarter of~~ 2020 has created significant volatility, uncertainty and disruption to the global economy. ~~We are closely monitoring the~~This pandemic has had an unfavorable impact ~~of the COVID-19 pandemic~~ on ~~all~~ aspects of our business, ~~including how it will impact~~operations, and financial results, and has caused us to significantly change the way we operate. Near the end of the first quarter of 2020, we suspended almost all business travel and our ~~clients,~~ employees ~~and business partners. In response to the pandemic, many state and local governments have issued shelter-in-place mandates; and companies, including Huron, have implemented work~~began working from ~~home policies and travel restrictions.~~their homes. While traditionally a majority of the work performed by our revenue-generating professionals ~~occurs~~occurred at client sites, the nature of the services we provide and enhanced available technology allows ~~for~~ our revenue-generating professionals to ~~continue to~~effectively serve clients in a remote work environment. ~~While~~As state and local governments ease their restrictions, we continue to refine our comprehensive plan to return to our offices and client sites with our people’s safety and the ~~COVID-19 pandemic did not have a significant impact on~~needs of our ~~consolidated revenues in the first quarter~~clients guiding how we implement our phased transition. As of ~~2020, we expect it~~March 31, 2021, our employees continue to have an unfavorable impact on sales and business development activities and full year 2020 results. However, given the dynamic nature of these circumstances, the full impact of the COVID-19 pandemic on our consolidated operations and overall financial performance is uncertain at this time.primarily work from their homes.

In each of our operating segments, we are working closely with our clients to support them and totheir ongoing business needs and provide relevant services to address their needs caused by the COVID-19 pandemic. However, as some clients reprioritized and delayed projects as a result of the pandemic, demand for certain offerings has been negatively impacted, particularly within our Healthcare and Education segments. Total revenues in the first quarter of 2021 decreased 8.7% compared to the first quarter of 2020, which was not significantly impacted by the pandemic. In addition to the impact on first quarter 2021 revenues, the COVID-19 pandemic negatively impacted sales and elongated the sales cycle for new opportunities for certain services, particularly within our Healthcare and Education segments. Given the uncertainties around the duration of the COVID-19 pandemic, we continue to remain cautious about revenue growth for the first half of 2021 when compared to the first half of 2020.

The COVID-19 pandemic has strengthened demand for other services we provide, ~~may be considered by~~such as our ~~clients~~cloud-based technology and analytics solutions within our Business Advisory segment and our restructuring and capital advisory solutions provided to ~~be more discretionary~~organizations in ~~nature and the COVID-19 pandemic is expected to have a negative impact on the demand for those services. In addition, conditions in the financial markets could limit~~transition also within our ~~access to further capital resources, if needed, and could increase borrowing costs.~~ Business Advisory segment.

In order to support our liquidity during the COVID-19 pandemic, we ~~are proactively taking~~took proactive measures to increase available cash on hand including, but not limited to, borrowing under our senior secured credit facility in the first quarter of 2020 and reducing discretionary operating and capital spending. In the second, third and fourth quarters of 2020, we made repayments on our borrowings to reduce our total debt outstanding to pre-pandemic levels due to our ability to maintain adequate cash flows from operations and improved clarity around access to capital resources. In the first quarter of 2021, we borrowed under our credit facility primarily to fund our annual performance bonus payment. To further support our liquidity during the COVID-19 pandemic, we ~~have~~ elected to defer the deposit of our employer portion of social security taxes beginning in April 2020 and through ~~the end of the year,~~December 31, 2020, which we expect to pay in equal installments in the fourth quarters of 2021 and 2022, as provided for under ~~the~~ CARES Act.

The services provided by our Strategy and Innovation and Life Sciences reporting units within our Business Advisory segment focus on strategic solutions for healthy, well-capitalized companies to identify new growth opportunities and may be considered by our clients to be more discretionary in nature. As discussed above, the COVID-19 pandemic is expected to have an unfavorable impact on the demand for those services. Based on our internal projections and the preparation of our financial statements for the quarter ended March 31, 2020, and considering the expected decrease in demand due to the COVID-19 pandemic, we believed that the fair value of these two reporting units may no longer exceed their carrying values and performed an interim goodwill impairment test on both reporting units. Based on the estimated fair values of the Strategy and Innovation and Life Sciences reporting units, we recorded non-cash pretax goodwill impairment charges of $49.9 million and $9.9 million, respectively. We did not identify any indicators that would lead us to believe that the fair values of our Healthcare, Education, and Business Advisory reporting units may not exceed their carrying values. See the ~~"Critical Accounting Policies"~~“Liquidity and Capital Resources” section below ~~and Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements~~ for additional information on these items.

Enterprise Resource Planning System Implementation

In the ~~charges~~fourth quarter of 2019, we began the implementation of a new cloud-based enterprise resource planning (“ERP”) system designed to improve the efficiency of our internal finance, human resources, resource planning, and ~~evaluations performed.~~

~~See Part II, Item 1A. "Risk Factors" of this Quarterly Report~~administrative operations. In January 2021, we successfully went live with the new ERP system, and we continue to progress with additional functionality and integrations as scheduled. The implementation progressed on ~~Form 10-Q for additional information on the potential impact~~schedule and has not been significantly impacted by the COVID-19 pandemic ~~could have on~~due to the ability of our ~~business, operations~~implementation team to work and ~~financial results.~~collaborate remotely and the enhanced technology and cloud-based nature of our new ERP system. We believe our investment in this new system will position our teams to drive efficiencies and provide more robust management reporting and data analytics to support future growth and the goals and vision of the company.

Table of Contents

How We Generate Revenues

A large portion of our revenues is generated by our ~~full-time~~billable consultants who provide consulting services to our clients and are billable to our clients based on the number of hours worked. A smaller portion of our revenues is generated by our other professionals, also referred to as full-time equivalents, some of whom work variable schedules as needed by our clients. Full-time equivalent professionals consist of our coaches and their

~~Table of Contents~~

support staff from our Culture and Organizational Excellence solution, consultants who work variable schedules as needed by our clients, employees who provide managed services in our Healthcare segment, and our employees who provide software support and maintenance services to our clients. We translate the hours that these other professionals work on client engagements into a full-time equivalent measure that we use to manage our business. We refer to our ~~full-time~~billable consultants and other professionals collectively as revenue-generating professionals.

Revenues generated by our ~~full-time~~billable consultants are primarily driven by the number of consultants we employ and their utilization rates, as well as the billing rates we charge our clients. Revenues generated by our other professionals, or full-time equivalents, are largely dependent on the number of consultants we employ, their hours worked, and billing rates charged. Revenues generated by our coaches are largely dependent on the number of coaches we employ and the total value, scope, and terms of the consulting contracts under which they provide services, which are primarily fixed-fee contracts. Revenues generated by our ~~Managed Services~~healthcare managed services solution are dependent on the total value, scope and terms of the related contracts.

We generate our revenues from providing professional services under four types of billing arrangements: fixed-fee (including software license revenue); time-and-expense; performance-based; and software support, maintenance and subscriptions.

In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements. It is the client’s expectation in these engagements that the pre-established fee will not be exceeded except in mutually agreed upon circumstances. We generally recognize revenues under fixed-fee billing arrangements using a proportionate performance approach, which is based on work completed to-date versus our estimates of the total services to be provided under the engagement. Contracts within our Culture and Organizational Excellence solution include fixed-fee partner contracts with multiple performance obligations (“Partner Contracts”), which primarily consist of coaching services, as well as speaking engagements, conferences, publications and software ~~products (“Partner Contracts”).~~products. Revenues for coaching services and software products are generally recognized on a straight-line basis over the length of the contract. All other revenues under Partner Contracts, including speaking engagements, conferences and publications, are recognized at the time the goods or services are provided.

Fixed-fee arrangements also include software licenses for our revenue cycle management software and research administration and compliance software. Licenses for our revenue cycle management software are sold only as a component of our consulting projects, and the services we provide are essential to the functionality of the software. Therefore, revenues from these software licenses are recognized over the term of the related consulting services contract. License revenue from our research administration and compliance software is generally recognized in the month in which the software is delivered.

Fixed-fee engagements represented ~~42.4%~~46.0% and ~~47.8%~~42.4% of our revenues for the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, respectively.

Time-and-expense billing arrangements require the client to pay based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include certain speaking engagements, conferences and publications purchased by our clients outside of Partner Contracts within our Culture and Organizational Excellence solution. We recognize revenues under time-and-expense billing arrangements as the related services or publications are provided. Time-and-expense engagements represented ~~43.1%~~38.3% and ~~40.8%~~43.1% of our revenues for the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, respectively.

In performance-based fee billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we have performance-based engagements in which we earn a success fee when and if certain predefined outcomes occur. Often, performance-based fees supplement our time-and-expense or fixed-fee engagements. We recognize revenues under performance-based billing arrangements by estimating the amount of variable consideration that is probable of being earned and recognizing that estimate over the length of the contract using a proportionate performance approach. Performance-based fee revenues represented ~~8.8%~~8.9% and ~~6.1%~~8.8% of our revenues for the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, respectively. The level of performance-based fees earned may vary based on our clients' risk sharing preferences and the mix of services we provide.

Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. We also generate subscription revenue from our cloud-based analytic tools and solutions. Software support, maintenance and subscription revenues are recognized ratably over the support or subscription period. These fees are generally billed in advance and included in deferred revenues until recognized. Software support, maintenance and subscription revenues represented ~~5.7%~~6.8% and ~~5.3%~~5.7% of our revenues for the three months ended March 31, 2021 and 2020, ~~and 2019,~~ respectively.

Table of Contents

Our quarterly results are impacted principally by our ~~full-time~~billable consultants’ utilization rate, the bill rates we charge our clients, and the number of our revenue-generating professionals who are available to work. Our utilization rate can be negatively affected by increased hiring because there is generally a transition period for new professionals that results in a temporary drop in our utilization rate. Our utilization rate can also be affected by seasonal variations in the demand for our services from our clients. For example, during the third and fourth quarters of the year, vacations taken by our clients can result in the deferral of activity on existing and new engagements, which would negatively affect our utilization rate. The number of business work days is also affected by the number of vacation days taken by our consultants and holidays in each quarter. We typically have fewer business work days available in the fourth quarter of the year, which can impact revenues during that period.

~~Table of Contents~~

Time-and-expense engagements do not provide us with a high degree of predictability as to performance in future periods. Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.

Business Strategy, Opportunities and Challenges

Our primary strategy is to meet the needs of our clients by providing a balanced portfolio of service offerings and capabilities so that we can adapt quickly and effectively to emerging opportunities in the marketplace. To achieve this, we continue to hire highly qualified professionals and have entered into select acquisitions of complementary businesses.

To expand our business, we will remain focused on growing our existing relationships and developing new relationships, executing our managing director compensation plan to attract and retain senior practitioners, continuing to promote and provide an integrated approach to service delivery, broadening the scope of our existing services, and acquiring complementary businesses. We will regularly evaluate the performance of our practices to ensure our investments meet these objectives. Furthermore, we intend to enhance our visibility in the marketplace by refining our overarching messaging and value propositions for the organization as well as each practice. We will continue to focus on reaching our client base through clear, concise, and endorsed messages.

Table of Contents

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, selected segment and consolidated operating results and other operating data.

Segment and Consolidated Operating Results
(in thousands, except per share amounts):
Three Months Ended
March 31,
2020 2019
Healthcare:
Revenues $ 95,578
$ 93,682
Operating income $ 24,050
$ 27,851
Segment operating income as a percentage of segment revenues 25.2 % 29.7 %
Business Advisory:
Revenues $ 64,905
$ 58,806
Operating income $ 9,842
$ 9,581
Segment operating income as a percentage of segment revenues 15.2 % 16.3 %
Education:
Revenues $ 62,136
$ 51,957
Operating income $ 13,116
$ 12,618
Segment operating income as a percentage of segment revenues 21.1 % 24.3 %
Total Company:
Revenues $ 222,619
$ 204,445
Reimbursable expenses 19,303
18,617
Total revenues and reimbursable expenses $ 241,922
$ 223,062
Statements of Operations reconciliation:
Segment operating income $ 47,008
$ 50,050
Items not allocated at the segment level:
Other operating expenses 27,146
36,578
Litigation and other gains (150 ) (456 )
Depreciation and amortization 6,047
7,172
Goodwill impairment charges ⁽¹⁾
59,816
—
Operating income (loss) (45,851 ) 6,756
Other expense, net (7,637 ) (2,041 )
Income (loss) from continuing operations before taxes (53,488 ) 4,715
Income tax expense (benefit) (11,215 ) 1,365
Net income (loss) from continuing operations $ (42,273 ) $ 3,350
Earnings (loss) per share from continuing operations:
Basic $ (1.94 ) $ 0.15
Diluted $ (1.94 ) $ 0.15


Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended March 31,
		2021			2020
Healthcare:
Revenues		$	79,722		$	95,578
Operating income		$	20,484		$	24,050
Segment operating income as a percentage of segment revenues		25.7		%	25.2		%
Business Advisory:
Revenues		$	72,867		$	64,905
Operating income		$	13,077		$	9,842
Segment operating income as a percentage of segment revenues		17.9		%	15.2		%
Education:
Revenues		$	50,624		$	62,136
Operating income		$	8,653		$	13,116
Segment operating income as a percentage of segment revenues		17.1		%	21.1		%
Total Company:
Revenues		$	203,213		$	222,619
Reimbursable expenses		1,934			19,303
Total revenues and reimbursable expenses		$	205,147		$	241,922
Statements of Operations reconciliation:
Segment operating income		$	42,214		$	47,008
Items not allocated at the segment level:
Other operating expenses		28,837			27,146
Litigation and other losses (gains)		42			(150)
Depreciation and amortization		5,095			6,047
Goodwill impairment charges (1)		—			59,816
Operating income (loss)		8,240			(45,851)
Other expense, net		(1,299)			(7,637)
Income (loss) from continuing operations before taxes		6,941			(53,488)
Income tax expense (benefit)		1,536			(11,215)
Net income (loss) from continuing operations		$	5,405		$	(42,273)
Earnings (loss) per share from continuing operations:
Basic		$	0.25		$	(1.94)
Diluted		$	0.24		$	(1.94)

Table of Contents


	Three Months Ended March 31,
Other Operating Data:		2021			2020
Number of billable consultants (at period end) (2):
Healthcare		821			892
Business Advisory		1,107			916
Education		726			791
Total		2,654			2,599
Average number of billable consultants (for the period) (2):
Healthcare		822			897
Business Advisory		1,080			920
Education		731			778
Total		2,633			2,595
Billable consultant utilization rate (3):
Healthcare		67.9		%	71.6		%
Business Advisory		68.7		%	71.5		%
Education		70.1		%	76.2		%
Total		68.8		%	72.9		%
Billable consultant average billing rate per hour (4):
Healthcare		$	236		$	228
Business Advisory (5)		$	203		$	198
Education		$	174		$	188
Total (5)		$	205		$	204
Revenue per billable consultant (in thousands):
Healthcare		$	73		$	73
Business Advisory		$	63		$	67
Education		$	59		$	69
Total		$	65		$	70
Average number of full-time equivalents (for the period) (6):
Healthcare		258			278
Business Advisory		34			20
Education		36			60
Total		328			358
Revenue per full-time equivalent (in thousands):
Healthcare		$	78		$	108
Business Advisory		$	89		$	149
Education		$	227		$	144
Total		$	95		$	117

(1)The non-cash goodwill impairment charges are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance.

(2)Consists of our consulting professionals who provide consulting services and generate revenues based on the number of hours worked.

Three Months Ended
March 31,
Other Operating Data: 2020 2019
Number of full-time billable consultants (at period end) ⁽²⁾:

Healthcare 892
836
Business Advisory 916
864
Education 791
649
Total 2,599
2,349
Average number of full-time billable consultants (for the period) ⁽²⁾:

Healthcare 897
819
Business Advisory 920
839
Education 778
631
Total 2,595
2,289
Full-time billable consultant utilization rate ⁽³⁾:

Healthcare 71.6 % 78.6 %
Business Advisory 71.5 % 73.1 %
Education 76.2 % 76.4 %
Total 72.9 % 75.9 %
Full-time billable consultant average billing rate per hour ⁽⁴⁾:

Healthcare $ 228
$ 224
Business Advisory ⁽⁵⁾
$ 198
$ 200
Education $ 188
$ 204
Total ⁽⁵⁾
$ 204
$ 210
Revenue per full-time billable consultant (in thousands):
Healthcare $ 73
$ 79
Business Advisory $ 67
$ 68
Education $ 69
$ 73
Total $ 70
$ 73
Average number of full-time equivalents (for the period) ⁽⁶⁾:

Healthcare 278
223
Business Advisory 20
8
Education 60
36
Total 358
267
Revenue per full-time equivalent (in thousands):
Healthcare $ 108
$ 129
Business Advisory $ 149
$ 206
Education $ 144
$ 166
Total $ 117
$ 137
(3)Utilization rate for our billable consultants is calculated by dividing the number of hours our billable consultants worked on client assignments during a period by the total available working hours for these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days.


~~(1)~~	The non-cash goodwill impairment charges are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance.


~~(2)~~	~~Consists of our full-time professionals who provide consulting services and generate revenues based on the number of hours worked.~~


~~(3)~~	Utilization rate for our full-time billable consultants is calculated by dividing the number of hours our full-time billable consultants worked on client assignments during a period by the total available working hours for these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days.


~~(4)~~	~~Average billing rate per hour for our full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period.~~


~~(5)~~	The Business Advisory segment includes operations of Huron Eurasia India. Absent the impact of Huron Eurasia India, the average billing rate per hour for the Business Advisory segment would have been $224 and $223 for the three months ended March 31, 2020 and 2019, respectively.

(4)Average billing rate per hour for our billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period.

(5)The Business Advisory segment includes operations of Huron Eurasia India. Absent the impact of Huron Eurasia India, the average billing rate per hour for the Business Advisory segment would have been $221 and $224 for the three months ended March 31, 2021 and 2020, respectively.

Absent the impact of Huron Eurasia India, Huron's consolidated average billing rate per hour would have been ~~$213~~$212 and ~~$218~~$213 for the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, respectively.

(6)Consists of coaches and their support staff within our Culture and Organizational Excellence solution, consultants who work variable schedules as needed by our clients, employees who provide managed services in our Healthcare segment, and full-time employees who provide software support and maintenance services to our clients.

Table of Contents


~~(6)~~	Consists of coaches and their support staff within our Culture and Organizational Excellence solution, consultants who work variable schedules as needed by our clients, employees who provide managed services in our Healthcare segment, and full-time employees who provide software support and maintenance services to our clients.

Non-GAAP Measures

We also assess our results of operations using certain non-GAAP financial measures. These non-GAAP financial measures differ from GAAP because the non-GAAP financial measures we calculate to measure earnings ~~(loss)~~ before interest, taxes, depreciation and amortization ("EBITDA"), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income from continuing operations, and adjusted diluted earnings per share from continuing operations exclude a number of items required by GAAP, each discussed below. These non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows, or liquidity prepared in accordance with GAAP. Our non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar terms used by other companies, and accordingly, care should be exercised in understanding how we define our non-GAAP financial measures.

Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results.

The reconciliations of these financial measures from GAAP to non-GAAP are as follows (in thousands, except per share amounts):

Three Months Ended
March 31,
2020 2019
Revenues $ 222,619
$ 204,445
Net income (loss) from continuing operations $ (42,273 ) $ 3,350
Add back:
Income tax expense (benefit) (11,215 ) 1,365
Interest expense, net of interest income 2,341
4,258
Depreciation and amortization 7,415
8,289
Earnings (loss) before interest, taxes, depreciation and amortization (EBITDA) (43,732 ) 17,262
Add back:
Restructuring and other charges 2,458
1,275
Litigation and other gains (150 ) (456 )
Goodwill impairment charges 59,816
—
Loss on sale of business 102
—
Foreign currency transaction losses (gains), net 520
(82 )
Adjusted EBITDA $ 19,014
$ 17,999
Adjusted EBITDA as a percentage of revenues 8.5 % 8.8 %


	Three Months Ended March 31,
		2021			2020
Revenues		$	203,213		$	222,619
Net income (loss) from continuing operations		$	5,405		$	(42,273)
Add back:
Income tax expense (benefit)		1,536			(11,215)
Interest expense, net of interest income		1,719			2,341
Depreciation and amortization		6,551			7,415
Earnings (loss) before interest, taxes, depreciation and amortization (EBITDA)		15,211			(43,732)
Add back:
Restructuring and other charges		628			2,458
Litigation and other losses (gains)		42			(150)
Goodwill impairment charges		—			59,816
Loss on sale of business		—			102
Transaction-related expenses		170			—
Foreign currency transaction losses (gains), net		403			520
Adjusted EBITDA		$	16,454		$	19,014
Adjusted EBITDA as a percentage of revenues		8.1		%	8.5		%

Table of Contents


	Three Months Ended March 31,							Three Months Ended March 31,
	2020			2019					2021		2020
Net income (loss) from continuing operations	$	(42,273	)	$	3,350		Net income (loss) from continuing operations		$	5,405	$	(42,273)
Weighted average shares - diluted	21,827			22,311			Weighted average shares - diluted		22,341		21,827
Diluted earnings (loss) per share from continuing operations	$	(1.94	)	$	0.15		Diluted earnings (loss) per share from continuing operations		$	0.24	$	(1.94)
Add back:							Add back:
Amortization of intangible assets	3,209			4,517			Amortization of intangible assets		2,399		3,209
Restructuring and other charges	2,458			1,275			Restructuring and other charges		628		2,458
Litigation and other gains	(150		)	(456		)
Litigation and other losses (gains)							Litigation and other losses (gains)		42		(150)
Goodwill impairment charges	59,816			—			Goodwill impairment charges		—		59,816
Non-cash interest on convertible notes	—			2,120
Loss on sale of business	102			—			Loss on sale of business		—		102
Transaction-related expenses							Transaction-related expenses		170		—
Tax effect of adjustments	(13,409		)	(1,953		)	Tax effect of adjustments		(858)		(13,409)

Total adjustments, net of tax	52,026			5,503			Total adjustments, net of tax		2,381		52,026
Adjusted net income from continuing operations	$	9,753		$	8,853		Adjusted net income from continuing operations		$	7,786	$	9,753
Weighted average shares - diluted	22,329			22,311
Adjusted weighted average shares - diluted							Adjusted weighted average shares - diluted		22,341		22,329
Adjusted diluted earnings per share from continuing operations	$	0.44		$	0.40		Adjusted diluted earnings per share from continuing operations		$	0.35	$	0.44

These non-GAAP financial measures include adjustments for the following items:

Amortization of intangible assets: We have excluded the effect of amortization of intangible assets from the calculation of adjusted net income from continuing operations presented above. Amortization of intangible assets is inconsistent in its amount and frequency and is significantly affected by the timing and size of our acquisitions.

Restructuring and other charges: We have incurred charges due to the restructuring of various parts of our business. These restructuring charges have primarily consisted of costs associated with office space consolidations, including lease impairment charges and accelerated depreciation on lease-related property and equipment, and severance charges. Additionally, ~~during the first quarter of 2020,~~ we have excluded the effect of a $0.8 million one-time charge incurred during the first quarter of 2020, related to redundant administrative costs in our corporate operations which is recorded within selling, general and administrative expenses on our consolidated statement of operations. We have excluded the effect of the restructuring and other charges from our non-GAAP measures to permit comparability with periods that were not impacted by these items.

Litigation and other ~~gains:~~losses (gains): We have excluded the ~~effects~~effect of a loss in the first quarter of 2021 from an increase in the estimated fair value of our liability for contingent consideration payments related to a business acquisition and a litigation settlement gain recognized in the first quarter of 2020 ~~and the remeasurement gain recognized in the first quarter of 2019 to decrease the estimated fair value of our liabilities for contingent consideration payments related to business acquisitions~~ to permit comparability with periods that were not impacted by these items.

Goodwill impairment charges: We have excluded the effect of the goodwill impairment charges recognized in the first quarter of 2020 as these are infrequent events and their exclusion permits comparability with periods that were not impacted by such charges.

~~Non-cash interest on convertible notes:~~ We incurred non-cash interest expense relating to the implied value of the equity conversion component of our Convertible Notes. The value of the equity conversion component was treated as a debt discount and amortized to interest expense over the life of the Convertible Notes using the effective interest rate method. We exclude this non-cash interest expense that does not represent cash interest payments from the calculation of adjusted net income from continuing operations as management believes that this non-cash expense is not indicative of the ongoing performance of our business.

Loss on sale of business: We excluded the effect of the loss on sale of a software-based solution within our Business Advisory segment in the first quarter of 2020. Divestitures of businesses are infrequent and are not indicative of the ongoing performance of our business.

Transaction-related expenses: To permit comparability with prior periods, we excluded the impact of third-party legal and accounting fees incurred in the first quarter of 2021 related to the acquisition of Unico Solution, Inc. and ForceIQ, Inc., which closed effective February 1, 2021 and November 1, 2020, respectively.

Foreign currency transaction losses (gains), net: We have excluded the effect of foreign currency transaction losses and gains from the calculation of adjusted EBITDA because the amount of each loss or gain is significantly affected by changes in foreign exchange rates.

Tax effect of adjustments: The non-GAAP income tax adjustment reflects the incremental tax impact applicable to the non-GAAP adjustments.

Income tax expense, Interest expense, net of interest income, Depreciation and amortization: We have excluded the effects of income tax expense, interest expense, net of interest income, and depreciation and amortization in the calculation of EBITDA, as these are customary exclusions as defined by the calculation of EBITDA to arrive at meaningful earnings from core operations excluding the effect of such items. Included within the depreciation and amortization adjustment is the amortization of capitalized implementation costs of our ERP and other related software, which is included within Selling, general and administrative expenses on our consolidated statement of operations.

Adjusted weighted average shares - diluted: As we reported a net loss for the first three months of 2020, GAAP diluted weighted average shares outstanding equals the basic weighted average shares outstanding for that period. The non-GAAP adjustments described above resulted in adjusted

~~Table of Contents~~

net income from continuing operations for the first ~~quarter~~three months of 2020. Therefore, we included the dilutive common stock equivalents in the calculation of adjusted diluted weighted average shares outstanding for that period.

Table of Contents

Three Months Ended March 31, ~~2020~~2021 Compared to Three Months Ended March 31, ~~2019~~2020

Revenues

Revenues ~~increased $18.2~~decreased $19.4 million, or ~~8.9%~~8.7%, to $203.2 million for the first quarter of 2021 from $222.6 million for the first ~~three months~~quarter of 2020. Revenues in the first quarter of 2021 were negatively impacted by COVID-19 as some clients have reprioritized and delayed projects as a result of the pandemic, particularly within our Healthcare and Education segments, whereas revenues in the first quarter of 2020 ~~from $204.4 million~~were not significantly impacted by the pandemic. Conversely, the COVID-19 pandemic has strengthened demand for ~~the first three months of 2019.~~ other services we provide, such as our cloud-based technology and analytics solutions within our Business Advisory segment and our restructuring and capital advisory solutions provided to organizations in transition in our Business Advisory segment.

Of the ~~overall $18.2~~$19.4 million ~~increase~~decrease in revenues, ~~$12.9~~$10.5 million was attributable to ~~an increase~~a decrease in revenues from our full-time ~~billable consultants~~equivalents and ~~$5.3~~$8.9 million was attributable to a decrease in revenues from our ~~full-time equivalents.~~billable consultants.

The ~~increase~~decrease in full-time equivalent revenues was primarily attributable to a decrease in full-time equivalent revenues in our Healthcare segment, as discussed below in Segment Results. The decrease in full-time equivalent revenues reflected overall decreases in revenue per full-time equivalent and the average number of full-time equivalents in the first quarter of 2021 compared to the same prior year period.

The decrease in billable consultant revenues ~~was attributable to~~reflected a decrease in demand for services in our Education and Healthcare segments, partially offset by a strengthened demand for services in ~~all of~~ our ~~segments,~~Business Advisory segment, as discussed below in Segment ~~Results; and reflected~~Results. The decrease in billable consultant revenues was primarily attributable to overall decreases in the consultant utilization rate, partially offset by an overall increase in the average number of ~~full-time~~ billable consultants ~~partially offset by overall decreases in the consultant utilization rate and the average billing rate during~~for the first ~~three months~~quarter of ~~2020~~2021 compared to the same prior year period.

~~The increase in full-time equivalent revenues was attributable to increases in full-time equivalent revenues in all~~In most of ~~our segments, as discussed below in Segment Results;~~2020 and ~~reflected an overall increase in the average number of full-time equivalents, partially offset by an overall decrease in revenue per full-time equivalent.~~

~~While the COVID-19 pandemic did not have a significant impact on our consolidated revenues in~~ the first quarter of ~~2020, we expect it to have an unfavorable impact on~~2021, the COVID-19 pandemic negatively impacted sales and ~~business development activities~~elongated the sales cycle for new opportunities for certain services, particularly within our Healthcare and ~~full year 2020 results. Additionally, we expect a decrease in~~Education segments where some clients reprioritized or delayed certain projects. Given the ~~demand for~~uncertainties around the ~~services we provide that may be considered by our clients to be more discretionary in nature. However, given the dynamic nature of these circumstances, the full impact~~duration of the COVID-19 pandemic, onwe continue to remain cautious about revenue growth for the first half of 2021 when compared to the first half of 2020.

The COVID-19 pandemic has caused the need for many companies to accelerate their digital transformation to drive operational efficiencies, better engage with their customers, and make better data-driven decisions. This has resulted in strong demand for our ~~consolidated revenues is uncertain at~~digital, technology and analytic offerings, particularly within our Business Advisory segment. Indicative of our expectations for future growth in this ~~time.~~segment, we continue to make investments in these offerings, both organically and through strategic acquisitions, such as our acquisitions of ForceIQ in November 2020 and Unico Solutions in February 2021, and the addition of new offerings and capabilities within this segment where we see strategic opportunities.

Total Direct Costs

~~Our total direct~~Direct costs, ~~including~~excluding amortization of intangible assets and software development costs, ~~increased $18.7~~decreased $8.1 million, or ~~13.4%~~5.2%, to ~~$157.5~~$148.1 million for the three months ended March 31, ~~2020,~~2021, from ~~$138.9~~$156.2 million for the three months ended March 31, ~~2019.~~2020. The ~~overall $18.7~~$8.1 million ~~increase~~decrease primarily related to a ~~$15.3~~$3.0 million ~~increase~~decrease in salaries and related expenses for our revenue-generating professionals, ~~which was largely driven by increased headcount in all our segments;~~ a ~~$2.3~~$1.3 million ~~increase~~decrease in share-based compensation expense for our revenue-generating ~~professionals;~~professionals, a ~~$1.2~~$1.3 million increase in contractor expenses; and a $0.7 million increase in technology expenses. As a percentage of revenues, our total direct costs increased to 70.8% during the first three months of 2020 compared to 67.9% during the first three months of 2019 primarily due to the increases in salaries and related expenses and share-based compensation for our revenue-generating professionals, both as percentages of revenues, partially offset by a decrease in performance bonus expense for our revenue-generating ~~professionals.~~professionals, and a $1.3 million decrease in contractor expense. As a percentage of revenues, direct costs increased to 72.9% during the first quarter of 2021 compared to 70.2% during the first quarter of 2020, primarily due to the decrease in revenues.

Total direct costs for the three months ended March 31, ~~2020~~2021 included ~~$1.3~~$0.9 million of amortization expense for internal software development costs and intangible assets, compared to ~~$1.1~~$1.3 million of amortization expense for the same prior year period. Intangible asset amortization included within direct costs for the three months ended March 31, 2021 and 2020 ~~and 2019~~primarily related to technology and software, certain customer relationships and customer contracts acquired in connection with our business acquisitions. See Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information ~~about~~on our intangible assets.

Operating Expenses and Other Losses (Gains), Net

Selling, general and administrative expenses decreased ~~$7.3~~by $3.7 million, or ~~14.4%~~8.5%, to $39.8 million in the first quarter of 2021 from $43.4 million in the ~~three months ended March 31, 2020, from $50.7~~first quarter of 2020. The overall $3.7 million decrease primarily related to a $4.2 million decrease in practice administration and meetings expenses; $2.5 million decrease in promotion and marketing expenses; a $1.4 million decrease in share-based compensation expense for our support personnel; a $0.7 million decrease in training expenses; and a $0.7 million decrease in salaries and related expenses for our support personnel. These decreases were partially offset by a $5.5 million increase in deferred compensation expense attributable to the change in the ~~three months ended March 31, 2019. Of~~market value of our deferred compensation liability. During the ~~overall $7.3~~first quarter of 2021, the market value of our deferred compensation liability increased by $0.8 million, compared to a $4.7 million decrease ~~$6.9~~in the first quarter of 2020. This $5.5 million increase in expense is offset by a $5.5 million increase in the gain recognized for the change in the market value of investments that are used to fund our deferred compensation liability and recognized in other income (expense), net. The decreases in practice administration and meetings expenses, promotion and marketing expenses, and training expenses primarily relate to the cancellation or delay of in-person meetings and events and business travel due to the COVID-19 pandemic. The decrease in share-based compensation expense primarily related to a decrease in the expected funding of performance-based share awards for our

Table of Contents

executive officers recorded in the first quarter of 2021. As a percentage of revenues, selling, general and administrative expenses increased to 19.6% during the first quarter of 2021 compared to 19.5% during the first quarter of 2020. This increase was primarily attributable to the change in the market value of our deferred compensation liability ~~resulting from a $4.7 million~~and the decrease in the market value during the first quarter of 2020, compared to a $2.2 million increase in the market value during the first quarter of 2019. Additional decreases include a $2.3 million decrease in performance bonus expense for our support personnel; a $1.0 million decrease in facilities expense; a $0.7 million decrease in third-party consulting expenses; a $0.4 million decrease in training expenses; and a $0.4 million decrease in recruiting expenses. These decreases were partiallyrevenues, mostly offset by ~~a $1.8 million increase in salaries and related expenses for our support personnel; a $1.0 million increase~~the decreases in practice administration and meetings ~~expenses; a $0.8 million increase in share-based compensation expense for our support personnel;~~expenses and ~~a $0.8 million increase in data hosting~~promotion and software related expenses. As a percentage of revenues, selling, general and administrative expenses decreased to 19.5% during the first quarter of 2020 compared to 24.8% during the first quarter of 2019. This decrease was primarily attributable to the decreases in the market value of our deferred compensation liability, performance bonus expense for our support personnel, and facilitiesmarketing expenses.

Restructuring charges for the first ~~three months~~quarter of ~~2020 totaled $1.6~~2021 were $0.6 million, compared to ~~$1.3~~$1.6 million for the first ~~three months~~quarter of ~~2019.~~2020. The $0.6 million charge recognized in the first quarter of 2021 primarily related to rent and related expenses, net of sublease income, and accelerated depreciation on furniture and fixtures for vacated office spaces. The $1.6 million ~~restructuring~~ charge ~~incurred~~recognized in the first quarter of 2020 primarily related to a $1.2 million accrual for the termination of a third-party advisor agreement; $0.3 million related to workforce reductions to better align resources with market demand; and $0.1 million related to workforce reductions in our corporate operations. During the first quarter of 2019, we exited a portion of our Lake Oswego, Oregon corporate office resulting in a $0.7 million lease impairment charge on the related operating lease right-of-use asset and leasehold improvements and $0.2 million of accelerated depreciation on furniture and fixtures in that office. Additionally, we recognized a $0.2 million restructuring charge related to workforce reductions in

~~Table of Contents~~

~~our corporate operations.~~ See Note 8 "Restructuring Charges" within the notes to our consolidated financial statements for additional information on our restructuring charges.

Litigation and other gains totaled $0.2 million for the ~~three months ended March 31,~~first quarter of 2020, which consisted of a litigation settlement gain for the resolution of a claim that was settled in the first quarter of 2020. ~~Other gains totaled $0.5~~

Depreciation and amortization expense decreased $0.7 million, or 11.2%, to $5.4 million for the three months ended March 31, ~~2019, which primarily consisted of a $0.4 million remeasurement gain to decrease the estimated fair value of our liabilities for contingent consideration payments related to business acquisitions.~~

~~Depreciation and amortization expense decreased by $1.1 million, or 14.8%,~~2021 compared to $6.1 million for the three months ended March 31, ~~2020, from $7.2~~2020. The $0.7 million ~~for the three months ended March 31, 2019. The~~ decrease in depreciation and amortization expense was primarily attributable to ~~a decrease in amortization expense for the trade name acquired in our Studer Group acquisition that was fully amortized in the fourth quarter of 2019;~~ decreasing amortization expense for customer relationships acquired in business acquisitions due to the accelerated basis of amortization in prior periods, including the customer relationships acquired in our Studer Group acquisition; and customer relationships acquired in other business acquisitions that were fully amortized in prior ~~periods.~~periods; as well as a decrease in depreciation expense for leasehold improvements and furniture and fixtures related to vacated office spaces. Intangible asset amortization expense included within operating expenses ~~for the three months ended March 31, 2020 and 2019~~ primarily related to certain customer relationships, trade names, and non-competition agreements acquired in connection with our business acquisitions. See Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information ~~about~~on our intangible assets.

During the first quarter of 2020, we recorded $59.8 million of non-cash pretax goodwill impairment charges related to our Strategy and Innovation and Life Sciences reporting units within our Business Advisory segment; primarily related to the expected decline in sales, ~~and business development activities~~increased uncertainty in the backlog and a decrease in the demand for the services these reporting units provide, ~~that may be considered by our clients to be more discretionary in nature,~~ as a result of the COVID-19 pandemic. These charges ~~are~~were non-cash in nature and dodid not affect our liquidity or debt covenants. See ~~the "Critical Accounting Policies" section below and~~ Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information on the charges.

Operating Income

Operating income ~~decreased $52.6~~increased $54.1 million to income of $8.2 million in the first quarter of 2021 from a loss of $45.9 million in the first ~~three months~~quarter of ~~2020 from operating income of $6.8 million in the first three months of 2019.~~2020. This ~~decrease~~increase is primarily attributable to the $59.8 million of non-cash pretax goodwill impairment charges related to our Business Advisory segment that were recognized in the first quarter of 2020. ~~See~~Operating margin, which is defined as operating income expressed as a percentage of revenues, was 4.1% for the ~~"Critical Accounting Policies" section below~~three months ended March 31, 2021, compared to (20.6)% for the three months ended March 31, 2020. The increase in operating margin in the first quarter of 2021 was primarily attributable to the goodwill impairment charges recognized in the first quarter of 2020, as well as the decreases in practice administration and meetings expenses and promotion and marketing expenses in the first quarter of 2021 compared to the same prior year period. These increases to the operating margin were partially offset by the decrease in revenues and the change in the market value of our deferred compensation liability. See Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information on the non-cash goodwill impairment charges. Operating margin, which is defined as operating income expressed as a percentage of revenues, decreased to (20.6)% for the three months ended March 31, 2020, compared to an operating margin of 3.3% for the three months ended March 31, 2019. The decrease in operating margin was primarily attributable to the goodwill impairment charges, as well as the increases in salaries and related expenses and share-based compensation expense for our revenue-generating professionals, as percentages of revenues. These decreases to the operating margin were partially offset by the decreases in the market value of our deferred compensation liability, performance bonus expense for both our support personnel and revenue-generating professionals, intangible asset amortization expense, and facilities expenses.

~~Other Expense, Net~~

Total other expense, net increased by $5.6 million to $7.6 million in the first three months of 2020 from $2.0 million in the first three months of 2019. The increase in total other expense, net was primarily attributable to a $4.7 million loss recognized during the first three months of 2020 for the market value of our investments that are used to fund our deferred compensation liability, compared to a gain of $2.1 million gain during the first three months of 2019. Additionally, total other expense, net includes the recognition of $0.5 million of foreign currency transaction losses in the first three months of 2020 compared to $0.1 million of foreign currency transaction gains recognized in the first three months of 2019.Other Income (Expense), Net

Interest expense, net of interest income decreased ~~$1.9~~$0.6 million to $1.7 million in the first quarter of 2021 from $2.3 million in the first ~~three months~~quarter of ~~2020 from $4.3 million~~2020. The decrease in ~~the first three months of 2019,~~interest expense was primarily attributable to ~~the maturity of our Convertible Notes on October 1, 2019, partially offset by higher~~lower levels of borrowing under our credit facility during the first ~~three months~~quarter of ~~2020~~2021 compared to the same prior year period. See Note 7 "Financing Arrangements" within the notes to our consolidated financial statements for additional information about our ~~Convertible Notes and~~senior secured credit facility.

Other expense, net decreased $5.7 million to a net gain of $0.4 million in the first quarter of 2021 from a net loss of $5.3 million in the first quarter of 2020. The decrease in other expense, net was primarily attributable to a $0.8 million gain recognized in the first quarter of 2021 for the market value of our investments that are used to fund our deferred compensation liability, compared to a $4.7 million loss in the first quarter of 2020. Additionally, other expense, net includes $0.4 million of foreign currency transaction losses in the first quarter of 2021 compared to $0.5 million of foreign currency transaction losses recognized in the first quarter of 2020.

Income Tax Expense

OnFor the three months ended March 27, 2020, the President of the United States signed into law the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”). The CARES Act is an approximately $2 trillion emergency economic stimulus package in response to the COVID-19 outbreak, which among other items, includes31, 2021, our effective tax rate was 22.1% as we recognized income tax ~~provisions relating~~expense from continuing operations of $1.5 million on income from continuing operations of $6.9 million. The effective tax rate of 22.1% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to ~~net operating loss carryback periods and technical corrections to~~a discrete tax ~~depreciation methods~~benefit for ~~qualified improvement property. As a result of the enactment of this legislation~~share-based compensation awards that vested during the first quarter of ~~2020, we recorded a tax benefit~~2021. This favorable item was partially offset by certain nondeductible expense items.

Table of $0.8 million related to the remeasurement of a portion of our income tax receivable due to the ability to apply the federal net operating loss incurred in 2018 to prior year income for a refund at a higher tax rate in the carryback period.Contents

~~Table of Contents~~

inclusive of state income taxes, of 26.0% primarily due to certain nondeductible expense items, non-deductible losses on our investments used to fund our deferred compensation liability, and the nondeductible portion of the goodwill impairment charges recorded during the first quarter of 2020. These unfavorable items were partially offset by a discrete tax benefit for share-based compensation awards that vested during the quarter and the discrete tax benefit for the remeasurement of a portion of our income tax receivable as a result of the enactment of the CARES Act ~~during~~in the first quarter of 2020.

~~For~~The CARES Act, which was signed into law on March 27, 2020, is an approximately $2 trillion emergency economic stimulus package in response to the COVID-19 outbreak, which among other items, includes income tax provisions relating to net operating loss carryback periods and technical corrections to tax depreciation methods for qualified improvement property. During 2020, as a result of the CARES Act, we recognized a $1.5 million tax benefit related to the remeasurement of a portion of our income tax receivable for the federal net operating loss incurred in 2018 and the expected federal net operating loss in 2020 that will be carried back to prior year income, both for a refund at the higher, prior year tax rate.

See Note 12 "Income Taxes" within the notes to our consolidated financial statements for additional information on our income tax expense.

Net Income from Continuing Operations and Earnings per Share

Net income from continuing operations increased $47.7 million to $5.4 million for the three months ended March 31, ~~2019, our effective tax rate was 29.0% as we recognized income tax expense~~2021 from continuing operations of $1.4 million on income from continuing operations of $4.7 million. The effective tax rate of 29.0% was less favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to foreign losses with no tax benefit and disallowed executive compensation deductions. These unfavorable items were partially offset by a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2019.

~~Net Income from Continuing Operations~~

~~Net income from continuing operations decreased by $45.6 million to~~ a net loss from continuing operations of $42.3 million for the ~~three months ended March 31, 2020, from net income from continuing operations of $3.4 million for the~~ same ~~prior year period.~~period last year. This ~~decrease~~increase is primarily attributable to the $59.8 million of non-cash pretax goodwill impairment charges related to our Business Advisory ~~segment.~~segment recognized in the first quarter of 2020 . As a result of the ~~decrease~~increase in net income from continuing operations, diluted ~~loss~~earnings per share from continuing operations for the first ~~three months~~quarter of ~~2020~~2021 was ~~$1.94~~$0.24 compared to ~~diluted earnings~~a loss per share from continuing operations of ~~$0.15~~$1.94 for the first ~~three months~~quarter of ~~2019.~~2020. The non-cash goodwill impairment charges had a $2.19 unfavorable impact on diluted earnings per share from continuing operations for the first quarter of 2020.

EBITDA and Adjusted EBITDA

EBITDA ~~decreased $61.0~~increased $58.9 million to earnings of $15.2 million for the three months ended March 31, 2021 from a loss of $43.7 million for the three months ended March 31, ~~2020, from earnings of $17.3 million for the three months ended March 31, 2019.~~2020. Adjusted EBITDA ~~increased $1.0~~decreased $2.6 million to $16.5 million in the first quarter of 2021 from $19.0 million in the first ~~three months~~quarter of ~~2020 from $18.0 million in the first three months of 2019.~~2020. The ~~decrease~~increase in EBITDA was primarily attributable to the non-cash goodwill impairment charges of $59.8 million recognized in the first quarter of 2020. The ~~increase~~decrease in adjusted EBITDA was primarily attributable to the ~~increase in revenues and the~~ decrease in ~~performance bonus expense for our support personnel; largely offset by the increases~~segment operating income, as discussed below in ~~salaries and related expenses and share-based compensation expense for our revenue-generating professionals in the first three months of 2020 compared to the same prior year period.~~Segment Results.

Adjusted Net Income from Continuing Operations and Adjusted Earnings per Share

Adjusted net income from continuing operations ~~increased $0.9~~decreased $2.0 million to $7.8 million in the first quarter of 2021 compared to $9.8 million in the first ~~three months~~quarter of ~~2020 compared to $8.9 million in the first three months of 2019.~~2020. As a result of the ~~increase~~decrease in adjusted net income from continuing operations, adjusted diluted earnings per share from continuing operations was $0.35 for the first ~~three months~~quarter of ~~2020 was $0.44~~2021, compared to ~~$0.40~~$0.44 for the first ~~three months~~quarter of ~~2019.~~2020.

Segment Results

Healthcare

Revenues

Healthcare segment revenues ~~increased $1.9~~decreased $15.9 million, or ~~2.0%~~16.6%, to $79.7 million for the first quarter of 2021 from $95.6 million for the first ~~three months~~quarter of 2020, ~~from $93.7 million~~primarily due to the negative impact of the COVID-19 pandemic on demand for our services within this segment, as some clients reprioritized and delayed certain projects as a result of the ~~first three months of 2019.~~uncertainties surrounding the pandemic.

During the three months ended March 31, ~~2020,~~2021, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented ~~58.4%~~60.5%, ~~15.4%~~14.3%, ~~19.8%~~18.4%, and ~~6.4%~~6.8% of this segment’s revenues, respectively, compared to ~~67.9%~~58.4%, ~~13.6%~~15.4%, ~~12.6%~~19.8%, and ~~5.9%~~6.4% of this segment’s revenues, respectively, for the same prior year period. Performance-based fee revenue was $14.7 million for the first quarter of 2021 compared to $18.9 million ~~during~~for the first ~~three months~~quarter of ~~2020, compared to $11.8 million during the first three months of 2019.~~2020. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide.

Of the overall ~~$1.9~~$15.9 million decrease in revenues, $10.0 million was attributable to a decrease in revenues from our full-time equivalents and $5.9 million was attributable to a decrease in revenues from our billable consultants. The decrease in full-time equivalent revenues reflected decreases in revenue per full-time equivalent and the average number of full-time equivalents in the first quarter of 2021 compared to the same prior year period. The decrease in revenues attributable to our billable consultants reflected decreases in the average number of billable consultants and the consultant utilization rate, partially offset by an increase in the average billing rate in the first quarter of 2021 compared to the same prior year period.

Table of Contents

Operating Income

Healthcare segment operating income decreased $3.6 million, or 14.8%, to $20.5 million for the three months ended March 31, 2021 from $24.1 million for the three months ended March 31, 2020. The Healthcare segment operating margin, defined as segment operating income expressed as a percentage of segment revenues, increased to 25.7% for the first quarter of 2021 from 25.2% in the same period last year. The increase in this segment’s operating margin was primarily attributable to decreases in practice administration and meetings expenses, performance bonus and share-based compensation expense for our revenue-generating professionals, product and event costs, and promotion and marketing expenses, largely offset by an increase in salaries and related expenses for our revenue-generating professionals as a percentage of revenues.

Business Advisory

Revenues

Business Advisory segment revenues increased $8.0 million, or 12.3%, to $72.9 million for the first quarter of 2021 from $64.9 million for the first quarter of 2020, primarily related to strengthened demand for our cloud-based technology and analytics solutions, our strategy and innovation solutions, and our restructuring and capital advisory solutions provided to organizations in transition.

During the three months ended March 31, 2021, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 41.0%, 51.6%, 4.7%, and 2.7% of this segment’s revenues, respectively, compared to 39.1%, 57.9%, 1.0%, and 2.0% of this segment's revenues, respectively, for the same prior year period. Performance-based fee revenue was $3.4 million for the first quarter of 2021 compared to $0.6 million for the first quarter of 2020. The level of performance-based fees earned may vary based on our clients’ preferences, the mix of services we provide, and the timing of transactions or milestones.

Of the overall $8.0 million increase in revenues, ~~$1.3~~$7.9 million was attributable to an increase in revenues from our billable consultants and $0.1 million was attributable to an increase in revenues from our full-time ~~equivalents and $0.6 million was attributable to our full-time billable consultants.~~equivalents. The increase in revenues ~~attributable to~~from our full-time equivalents reflected an increase in the average number of full-time equivalents, partially offset by a decrease in revenue per full-time equivalent in the first three months of 2020 compared to the same prior year period. The increase in revenues attributable to our full-time billable consultants reflected increases in the average number of ~~full-time~~ billable consultants and the average billing rate, partially offset by a decrease in the consultant utilization rate in the first ~~three months~~quarter of ~~2020~~2021 compared to the same prior year period. The slight increase in revenues generated by our full-time equivalents reflected an increase in the average number of full-time equivalents, largely offset by a decrease in revenue per full-time equivalent in the first quarter of 2021 compared to the same prior year period.

Operating Income

~~Healthcare~~Business Advisory segment operating income ~~decreased $3.8~~increased by $3.2 million, or ~~13.6%~~32.9%, to ~~$24.1~~$13.1 million for the three months ended March 31, ~~2020,~~2021 from ~~$27.9~~$9.8 million for the three months ended March 31, ~~2019.~~2020. The ~~Healthcare~~Business Advisory segment operating margin increased to 17.9% for the first quarter of 2021 from 15.2% in the same period last year. The increase in this segment’s operating margin was primarily attributable to decreases in restructuring charges and promotion and marketing expenses, partially offset by an increase in performance bonus expense for our revenue-generating professionals.

Education

Revenues

Education segment revenues decreased $11.5 million, or 18.5%, to $50.6 million for the first quarter of 2021 from $62.1 million for the first quarter of 2020. The decrease in revenues was related to the negative impact of the COVID-19 pandemic on demand for this segment's services as some clients reprioritized and delayed certain projects as a result of the uncertainties surrounding the pandemic.

During the three months ended March 31, 2021, revenues from fixed-fee engagements; time-and-expense engagements; and software support, maintenance and subscription arrangements represented 30.1%, 56.9%, and 13.0% of this segment’s revenues, respectively, compared to 21.2%, 70.3%, and 8.5% of this segment’s revenues, respectively, for the same prior year period.

Of the overall $11.5 million decrease in revenues, $10.9 million was attributable to a decrease in revenues from our billable consultants and $0.6 million was attributable to a decrease in revenues from our full-time equivalents. The decrease in revenues attributable to our billable consultants reflected decreases in the consultant utilization rate, average billing rate, and average number of billable consultants in the first quarter of 2021 compared to the same prior year period. The decrease in revenues from our full-time equivalents was primarily driven by a decreased use of contractors and project consultants. The overall decrease in full-time equivalent revenues reflected a decrease in the average number of full-time equivalents, partially offset by an increase in revenue per full-time equivalent in the first quarter of 2021 compared to the same prior year period.

Table of Contents

Operating Income

Education segment operating income decreased $4.5 million, or 34.0% to $8.7 million for the three months ended March 31, 2021 from $13.1 million for the three months ended March 31, 2020. The Education segment operating margin decreased to ~~25.2%~~17.1% for the first ~~three months~~quarter of ~~2020~~2021 from ~~29.7%~~21.1% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to ~~increases~~an increase in salaries and

~~Table of Contents~~

related expenses ~~for our revenue-generating professionals and share-based compensation expense~~ for our revenue generating professionals ~~both~~ as a percentage of ~~revenues,~~revenues; partially offset by ~~a decrease~~decreases in contractor expense, promotion and marketing expenses, and performance bonus expense for our revenue-generating professionals.

~~Business Advisory~~

~~Revenues~~

~~Business Advisory segment revenues increased $6.1 million, or 10.4%, to $64.9 million for the first three months of 2020 from $58.8 million for the first three months of 2019.~~

During the first three months of 2020, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 39.1%, 57.9%, 1.0%, and 2.0% of this segment’s revenues, respectively, compared to 36.9%, 60.0%, 1.1%, and 2.0% of this segment’s revenues, respectively, during the same prior year period. Performance-based fee revenue was $0.6 million for the first three months of 2020, compared to $0.7 million for the first three months of 2019. The level of performance-based fees earned may vary based on our clients’ preferences and the mix of services we provide.

Of the overall $6.1 million increase in revenues, $4.9 million was attributable to revenues generated by our full-time billable consultants and $1.2 million was attributable to our full-time equivalents. The increase in revenues from our full-time billable consultants was primarily driven by an increase in the average number of full-time billable consultants, partially offset by decreases in the consultant utilization rate and the average billing rate in the first three months of 2020 compared to the same prior year period. The increase in revenues from our full-time equivalents was driven by an increased use of contractors; and reflected an increase in the average number of full-time equivalents, partially offset by a decrease in revenue per full-time equivalent in the first three months of 2020 compared to the same prior year period.

~~Operating Income~~

Business Advisory segment operating income increased by $0.3 million, or 2.7%, to $9.8 million for the three months ended March 31, 2020, from $9.6 million for the three months ended March 31, 2019. The Business Advisory segment operating margin decreased to 15.2% for the first three months of 2020 from 16.3% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to a restructuring charge recorded in the first quarter of 2020 for the termination of a third-party advisor agreement, as well as increases in share-based compensation expense for our revenue-generating professionals, contractor expenses, and salaries and related expenses for our revenue-generating professionals, all as percentages of revenues. These decreases to the segment's operating margin were partially offset by decreases in promotion and marketing expenses and signing, retention and other bonus expenses for our revenue-generating professionals.

The non-cash goodwill impairment charges related to the Strategy and Innovation and Life Sciences reporting units within the Business Advisory segment, which are discussed above within consolidated results, are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segment. We do not include the impact of goodwill impairment charges in our evaluation of segment performance. See the "Critical Accounting Policies" section below and Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information on the charges and our goodwill balances. We will continue to evaluate goodwill for impairment during future periods. Any future significant decline in the performance of our Strategy and Innovation reporting unit could result in another non-cash goodwill impairment charge.

~~Education~~

~~Revenues~~

~~Education segment revenues increased $10.2 million, or 19.6%, to $62.1 million for the first three months of 2020 from $52.0 million for the first three months of 2019.~~

For the three months ended March 31, 2020, revenues from fixed-fee engagements; time-and-expense engagements; and software support, maintenance and subscription arrangements represented 21.2%, 70.3%, and 8.5% of this segment’s revenues, respectively, compared to 23.8%, 68.1%, and 8.1% of this segment's revenues, respectively, during the same prior year period.

Of the overall $10.2 million increase in revenues, $7.4 million was attributable to revenues generated by our full-time billable consultants and $2.8 million was attributable to revenues generated by our full-time equivalents. The increase in revenues from our full-time billable consultants reflected an increase in the average number of full-time billable consultants; partially offset by a decrease in the average billing rate in the first three months of 2020 compared to the same prior year period. The increase in revenues from our full-time equivalents was primarily driven by an increased use of contractors and project consultants as well as an increase in software subscriptions and data hosting revenues; and reflected an increase in the average number of full-time equivalents, partially offset by a decrease in revenue per full-time equivalent in the first three months of 2020 compared to the same prior year period.

~~Table of Contents~~

~~Operating Income~~

Education segment operating income increased $0.5 million, or 3.9%, to $13.1 million for the three months ended March 31, 2020, from $12.6 million for the three months ended March 31, 2019. The Education segment operating margin decreased to 21.1% for the first three months of 2020 from 24.3% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to increases in contractor expenses, practice administration and meetings expenses, and salaries and related expenses for our revenue-generating professionals, all as percentages of revenues .

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents ~~increased $139.4~~decreased $45.6 million to ~~$151.0~~$21.6 million at March 31, ~~2020~~2021 from ~~$11.6~~$67.2 million at December 31, ~~2019.~~2020. As of March 31, ~~2020,~~2021, our primary sources of liquidity are cash on hand, cash flows from our U.S. operations, and borrowing capacity available under our credit facility.


	Three Months Ended March 31,							Three Months Ended March 31,
Cash Flows (in thousands):	2020			2019			Cash Flows (in thousands):	2021		2020
Net cash used in operating activities	$	(56,146	)	$	(38,289	)	Net cash used in operating activities	$	(82,754)	$	(56,146)
Net cash used in investing activities	(18,395		)	(8,087		)	Net cash used in investing activities	(8,037)		(18,395)
Net cash provided by financing activities	214,089			21,722			Net cash provided by financing activities	45,082		214,089
Effect of exchange rate changes on cash	(143		)	73			Effect of exchange rate changes on cash	155		(143)
Net increase (decrease) in cash and cash equivalents	$	139,405		$	(24,581	)	Net increase (decrease) in cash and cash equivalents	$	(45,554)	$	139,405

Operating Activities

Net cash used in operating activities totaled $82.8 million for the three months ended March 31, 2021, compared to $56.1 million for the three months ended March 31, ~~2020, compared to of $38.3 million for the three months ended March 31, 2019, respectively.~~2020. Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, and deferred revenues. The volume of services rendered and the related billings and timing of collections on those billings, as well as payments of our accounts payable and salaries, bonuses, and related benefits to employees affect these account balances.

The increase in cash used in operating activities for the first three months of ~~2020~~2021 compared to the same prior year period was primarily attributable to ~~an increase~~a decrease in cash collections, partially offset by a decrease in the amount paid for annual performance bonuses ~~during~~in the ~~three months ended March 31, 2020~~first quarter of 2021 compared to the ~~three months ended March 31, 2019 and an increase~~first quarter of 2020, a decrease in payments to employees for salaries and related benefits, ~~partially offset by an increase~~and a decrease in ~~cash collections in~~selling, general and administrative expenses during the first ~~quarter~~three months of ~~2020~~2021 compared to the first ~~quarter~~three months of ~~2019.~~2020.

Investing Activities

Net cash used in investing activities was ~~$18.4~~$8.0 million and ~~$8.1~~$18.4 million for the three months ended March 31, 2021 and 2020, respectively.

The use of cash in the first three months of 2021 primarily consisted of $6.0 million for the purchase of a business; $1.4 million for payments related to internally developed software; and ~~2019, respectively.~~$0.6 million for purchases of property and equipment, primarily related to purchases of leasehold improvements for certain office spaces and computers and related equipment.

The use of cash in the first three months of 2020 primarily consisted of $13.0 million for the purchase of an additional convertible debt investment in

Shorelight Holdings, LLC; $2.9 million for payments related to internally developed software; $1.5 million for contributions to our life insurance policies which fund our deferred compensation plan; and $1.0 million for purchases of property and equipment, primarily related to purchases of furniture and leasehold improvements for new office spaces in certain locations.

~~The use of cash in the first three months of 2019 primarily consisted of $3.6 million for contributions to our life insurance policies which fund our deferred compensation plan;~~ ~~$2.3 million~~ ~~for purchases of property and equipment, primarily related to purchases of computers and related equipment; and~~ ~~$2.1 million~~ ~~for payments related to internally developed software.~~

In order to support our liquidity during the pandemic, we are proactively taking measures to increase available cash on hand, including reducing discretionary capital expenses. Therefore, as of March 31, 2020, weWe estimate that cash utilized for purchases of property and equipment and software development in ~~2020~~2021 will ~~be lower than originally estimated and~~ total approximately ~~$16~~$12 million to ~~$20 million. The purchases~~$18 million; primarily ~~consist~~consisting of ~~software development costs,~~ leasehold improvements for certain office locations, software development costs, and information technology ~~related equipment to support our corporate infrastructure.~~

~~Table of Contents~~

equipment.

Financing Activities

Net cash provided by financing activities was $45.1 million and $214.1 million for the three months ended March 31, ~~2020.~~ 2021 and March 31, 2020, respectively.

During the first three months of 2021, we borrowed $89.0 million, primarily to fund our annual performance bonus payment, and made repayments on our borrowings of $24.1 million. Additionally, during the first three months of 2021, we repurchased and retired $11.5 million of our common stock under our 2020 Share Repurchase Program, as defined below.

Table of Contents

During the first three months of 2020, we borrowed $281.0 million under our credit facility, including $125.0 million prior to March 31, 2020 to maintain excess cash and support liquidity during the period of uncertainty created by the COVID-19 pandemic, as well as to fund our annual performance bonus payment. During the first quarter of 2020, we made repayments on our borrowings of $38.1 million. Additionally, we repurchased and retired $20.9 million of our common stock under our 2015 Share Repurchase Program, as defined below, and settled $1.2 million of share repurchases that were accrued as of December 31, 2019.

Net cash used in financing activities was $21.7 million for the three months ended March 31, 2019. During the first three months of 2019, we borrowed $40.5 million under our credit facility, primarily to fund our annual performance bonus payment, and made repayments on our credit facility of $14.5 million.

Share Repurchase Program

~~We currently have~~In November 2020, our board of directors authorized a share repurchase program (the “2020 Share Repurchase Program”) permitting us to

repurchase up to $50 million of our common stock through December 31, 2021. The 2020 Share Repurchase Program was authorized

subsequent to the expiration of our prior share repurchase program (the “2015 Share Repurchase Program”) on October 31, 2020. The 2015

Share Repurchase Program permitted us to repurchase up to $125 million of our common stock through October 31, 2020. The 2020 ~~(the "Share~~ Share

Repurchase ~~Program").~~Program and 2015 Share Repurchase Program are collectively known as the “Share Repurchase Programs.” The amount and

timing of repurchases under the ~~repurchases~~Share Repurchase Programs were and will continue to be determined by management and ~~will~~ depend on a

variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions,

and applicable legal requirements. In

Under the ~~first quarter of~~ 2020 Share Repurchase Program, we repurchased and retired ~~313,998~~245,718 shares for ~~$20.9 million. Additionally,~~$13.2 million in the first quarter of ~~2020, we~~2021 of which $1.7 million settled in the ~~repurchase~~second quarter of ~~18,000 shares for $1.2 million that were accrued as of December 31, 2019.~~2021. As of March 31, ~~2020, less than $0.1~~2021, $31.8 million ~~remains~~remained available for share repurchases.

Financing Arrangements

At March 31, ~~2020,~~2021, we had ~~$448.0~~$265.0 million outstanding under our senior secured credit facility and ~~$3.7~~$3.2 million outstanding under a promissory note, as discussed below.

Senior Secured Credit Facility

The Company has a $600 million senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on September 27, 2024. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $750 million. Borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances. In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.00 to 1.00 upon the occurrence of certain transactions, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, we were in compliance with these financial covenants. Our Consolidated Leverage Ratio as of March 31, ~~2020~~2021 was ~~3.48~~2.64 to 1.00, compared to ~~1.64~~1.94 to 1.00 as of December 31, ~~2019.~~2020. Our Consolidated Interest Coverage Ratio as of March 31, ~~2020~~2021 was ~~15.13~~13.00 to 1.00, compared to ~~15.29~~12.51 to 1.00 as of December 31, 2019. The increase in our Consolidated Leverage Ratio as of March 31, 2019 compared to December 31, 2019 was driven by $125.0 million of borrowings under the Amended Credit Agreement prior to March 31, 2020 to maintain excess cash and support liquidity during the period of uncertainty created by the COVID-19 pandemic. As a result of these borrowings, cash and cash equivalents increased $139.4 million to $151.0 million at March 31, 2020 from $11.6 million at December 31, 2019.

~~Table of Contents~~

2020.

The Amended Credit Agreement contains restricted payment provisions, including a potential limit on the amount of dividends we may pay. Pursuant to the terms of the Amended Credit Agreement, if our Consolidated Leverage Ratio is greater than 3.25, the amount of dividends and other Restricted Payments (as defined in the Amended Credit Agreement) we may pay is limited to an amount up to $25 million.

Table of Contents

Principal borrowings outstanding under the Amended Credit Agreement at March 31, ~~2020~~2021 and December 31, ~~2019~~2020 totaled ~~$448.0~~$265.0 million and ~~$205.0~~$200.0 million, respectively. These borrowings carried a weighted average interest rate of ~~2.3%~~2.4% at March 31, ~~2020~~2021 and ~~3.0%~~2.5% at December 31, ~~2019~~2020, including the impact of the interest rate swaps described in Note 9 “Derivative Instruments and Hedging Activity” within the notes to the consolidated financial statements. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At March 31, ~~2020,~~2021, we had outstanding letters of credit totaling ~~$1.6~~$0.8 million, which are primarily used as security deposits for our office facilities. As of March 31, 2021, the unused borrowing capacity under the revolving credit facility was $334.2 million.

Promissory Note due 2024

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one-month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At March 31, 2021, the outstanding principal amount of the promissory note was $3.2 million, and the aircraft had a carrying amount of $4.3 million. At December 31, 2020, the outstanding principal amount of the promissory note was ~~$3.7~~$3.3 million, and the aircraft had a carrying amount of ~~$4.9 million. At December 31, 2019, the outstanding principal amount of the promissory note was $3.9 million, and the aircraft had a carrying amount of $5.1~~$4.4 million.

For further information, see Note 7 “Financing Arrangements” within the notes to the consolidated financial statements.

Future Financing Needs

Our current primary financing need is to support our operations during the COVID-19 pandemic. The pandemic ~~which~~ has created significant

volatility and uncertainty in the economy, which could limit our access to capital resources and could increase our borrowing costs. In order to

support our liquidity during the pandemic, we ~~are proactively taking~~took proactive measures to increase available cash on hand, including, but not limited to,

borrowing under our senior secured credit facility in the first quarter of 2020 and reducing discretionary operating and capital expenses. To

further support our liquidity, we ~~have~~ elected to defer the deposit of our employer portion of social security taxes beginning in April 2020 and

through ~~the end of the year,~~December 2020, which we expect to pay in equal installments in the fourth quarters of 2021 and 2022, as provided for under the

CARES Act. Our long-term financing need has been to fund our growth. Our growth strategy is to expand our service offerings, which may

require investments in new hires, acquisitions of complementary businesses, possible expansion into other geographic areas, and related

capital expenditures. We believe our internally generated liquidity, together with our available cash, and the borrowing capacity available

under our revolving credit facility will be adequate to support our current financing needs and long-term growth strategy. Our ability to secure

additional financing, if needed, in the future will depend on several factors, including our future profitability, the quality of our accounts

receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.

CONTRACTUAL OBLIGATIONS

For a summary of our commitments to make future payments under contractual obligations, see Item 7. "Management’s Discussion and Analysis of Financial Condition and Results of Operations – Contractual Obligations" in our Annual Report on Form 10-K for the year ended December 31, ~~2019.~~2020. As of March 31, ~~2020,~~2021, borrowings outstanding under our senior secured credit facility totaled ~~$448.0~~$265.0 million compared to ~~$205.0~~$200.0 million at December 31, ~~2019.~~2020. See the "Liquidity and Capital Resources" section above and Note 7 "Financing Arrangements" within the notes to our consolidated financial statements for additional information on our outstanding borrowings as of March 31, ~~2020.~~2021. There have been no other material changes to our contractual obligations since December 31, ~~2019.~~2020.

OFF-BALANCE SHEET ARRANGEMENTS

We are not a party to any material off-balance sheet arrangements.

CRITICAL ACCOUNTING POLICIES

Management’s discussion and analysis of financial condition and results of operations ~~are~~is based upon our consolidated financial statements, which have been prepared in accordance with ~~GAAP.~~accounting principles generally accepted in the United States of America ("GAAP"). We regularly review our financial reporting and disclosure practices and accounting policies to ensure that our financial reporting and disclosures provide accurate information relative to the current economic and business environment. The preparation of financial statements in conformity with GAAP requires management to make assessments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those policies that we believe present the most complex or subjective measurements and have the most potential to impact our financial position and operating results. While all decisions regarding accounting policies are important, we believe there are five accounting policies that could be considered critical: revenue recognition, allowances for doubtful accounts and unbilled services, business combinations, carrying values of goodwill and other intangible assets, and accounting for income

~~Table of Contents~~

taxes. For a detailed discussion of these critical accounting policies, see Item 7. "Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting

Table of Contents

Policies" in our Annual Report on Form 10-K for the year ended December 31, ~~2019. Below is an update to our critical accounting policy related to the carrying value of goodwill and other intangible assets.~~2020. There have been no material changes to our other critical accounting policies during the first three months of ~~2020.~~2021.

~~Carrying Values of Goodwill and Other Intangible Assets~~

~~First Quarter 2020 Goodwill Impairment Analysis~~

The worldwide spread of coronavirus (COVID-19) in the first quarter of 2020 has created significant volatility, uncertainty and disruption to the global economy. We are closely monitoring the impact of the COVID-19 pandemic on all aspects of our business, including how it will impact our clients, employees and business partners. While the COVID-19 pandemic did not have a significant impact on our consolidated revenues in the first quarter of 2020, we expect it to have an unfavorable impact on sales and business development activities and full year 2020 results. Additionally, we expect a decrease in the demand for the services we provide that may be considered by our clients to be more discretionary in nature. The services provided by our Strategy and Innovation and Life Sciences reporting units within our Business Advisory segment focus on strategic solutions for healthy, well-capitalized companies to identify new growth opportunities and may be considered by our clients to be more discretionary in nature; therefore, we are cautious about near-term results for these two reporting units. Based on our internal projections and the preparation of our financial statements for the quarter ended March 31, 2020, and considering the expected decrease in demand due to the COVID-19 pandemic, we believed that the fair value of these two reporting units may no longer exceed their carrying values and performed an interim impairment test on both reporting units.

Based on the estimated fair values of the Strategy and Innovation and Life Sciences reporting units described below, we recorded non-cash pretax goodwill impairment charges of $49.9 million and $9.9 million, respectively, in the first quarter of 2020. The $49.9 million non-cash pretax charge related to the Strategy and Innovation reporting unit reduced the goodwill balance of the reporting unit to $37.5 million. The $9.9 million non-cash pretax charge related to the Life Sciences reporting unit reduced the goodwill balance of the reporting unit to zero.

Our goodwill impairment test was performed by comparing the fair value of each of the Strategy and Innovation and Life Sciences reporting units with its respective carrying value and recognizing an impairment charge for the amount by which the carrying value exceeded the fair value. To estimate the fair value of each reporting unit, we relied on a combination of the income approach and the market approach, with a fifty-fifty weighting.

In the income approach, we utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be generated by each reporting unit and then discounting those cash flows to present value, reflecting the relevant risks associated with each reporting unit and the time value of money. This approach requires the use of significant estimates and assumptions, including long-term projections of future cash flows, market conditions, and discount rates that reflects the risk inherent in the future cash flows. In estimating future cash flows, we relied on internally generated seven-year forecasts. For periods after the seven-year forecast, we assumed a long-term annual revenue growth rate of 3.0% for both the Strategy and Innovation and Life Sciences reporting units. Our forecasts are based on historical experience, current backlog, expected market demand, and other industry information. Our discounted cash flow analysis assumed weighted average cost of capital discount rates of 16.0% and 10.5% for the Strategy and Innovation and Life Sciences reporting units, respectively.

In the market approach, we utilized the guideline company method, which involved calculating valuation multiples based on operating data from guideline publicly traded companies. Multiples derived from guideline companies provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples were evaluated and adjusted based on specific characteristics of the Strategy and Innovation and Life Sciences reporting units relative to the selected guideline companies and applied to the reporting units' operating data to arrive at an indication of value.

Determining the fair value of any reporting unit requires us to make significant judgments, estimates, and assumptions. While we believe that the estimates and assumptions underlying our valuation methodology are reasonable, these estimates and assumptions could have a significant impact on whether or not a non-cash impairment charge is recognized and also the magnitude of any such charge. The results of an impairment analysis are as of a point in time. There is no assurance that the actual future earnings or cash flows of our reporting units will be consistent with our projections. We will monitor any changes to our assumptions and will evaluate goodwill as deemed warranted during future periods. Any significant decline in our operations could result in additional non-cash goodwill impairment charges, which could be material.

Concurrently with the goodwill impairment tests performed over the Strategy and Innovation and Life Sciences reporting units, we evaluated whether any indicators exist that would lead us to believe that the fair values of our Healthcare, Education, and Business Advisory reporting units may not exceed their carrying values. Based on our internal projections, consideration of the impact of the COVID-19 pandemic on these reporting units, and review of the amounts by which the fair values of these reporting units exceeded their carrying values in the most recent quantitative goodwill impairment analysis performed, we did not identify any indicators that would lead us to believe that the fair values of these reporting units may not exceed their carrying values as of March 31, 2020. We will monitor any changes to our assumptions and will evaluate goodwill as deemed warranted during future periods.

~~Table of Contents~~

~~The carrying values of goodwill for each of our reporting units as of March 31, 2020 are as follows (in thousands):~~

Reporting Unit
Carrying Value
of Goodwill
Healthcare $ 428,729
Education 103,889
Business Advisory 16,094
Strategy and Innovation 37,523
Life Sciences —
Enterprise Solutions and Analytics —
Total $ 586,235

Intangible assets represent purchased assets that lack physical substance but can be distinguished from goodwill. Our intangible assets, net of accumulated amortization, totaled $28.1 million at March 31, 2020 and primarily consist of customer relationships, trade names, technology and software, non-competition agreements, and customer contracts, all of which were acquired through business combinations. We evaluate our intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. In connection with the goodwill impairment tests performed for the Strategy and Innovation and Life Sciences reporting units in the first quarter of 2020, which resulted in non-cash goodwill impairment charges, we performed impairment tests on the long-lived assets allocated to the asset groups of the Strategy and Innovation and Life Sciences reporting units. Based on the impairment tests performed, we concluded that the long-lived assets allocated to the asset groups were not impaired as of March 31, 2020. We did not identify any indicators that would lead us to believe that the carrying values of the long-lived assets allocated to our other asset groups may not be recoverable as of March 31, 2020.

NEW ACCOUNTING PRONOUNCEMENTS

Refer to Note 3 "New Accounting Pronouncements" within the notes to the consolidated financial statements for information on new accounting pronouncements.

SUBSEQUENT EVENTS

Healthcare Group Hiring



ITEM 3.			QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are exposed to market risks primarily from changes in interest rates and changes in the market value of our investments.

Market Risk and Interest Rate Risk

Concurrent with the issuance of our Convertible Notes, we entered into separate convertible note hedge and warrant transactions. The convertible note hedge transactions were intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raised the price at which economic dilution would occur from the initial conversion price of approximately 3.1 million shares of our common stock, which was the number of shares initially issuable upon conversion of the Convertible Notes in full, at a price of approximately $79.89 to $97.12 per share. The convertible note hedge transactions expired in the third quarter of 2019 and the warrants are expiring incrementally on 100 different dates from January 6, 2020 to May 28, 2020. See Note 7 “Financing Arrangements” within the notes to the consolidated financial statements for additional information on our Convertible Notes, which matured on October 1, 2019.

We have exposure to changes in interest rates associated with borrowings under our bank credit facility, which has variable interest rates tied to LIBOR or an alternate base rate, at our option. At March 31, ~~2020,~~2021, we had borrowings outstanding under the credit facility totaling ~~$448.0~~$265.0 million that carried a weighted average interest rate of ~~2.3%~~2.4%, including the impact of the interest rate swaps described below. A hypothetical 100 basis point change in the interest rate would have a ~~$2.5~~$0.7 million effect on our pretax income on an annualized basis, including the effect of the interest rate swaps outstanding at March 31, ~~2020.~~2021. At December 31, ~~2019,~~2020, we had borrowings outstanding under the credit facility totaling ~~$205.0~~$200.0 million that carried a weighted average interest rate of ~~3.0%~~2.5% including the impact of the interest rate ~~swap outstanding at~~swaps described below. As of December 31, ~~2019.~~2020, these variable rate borrowings were fully hedged against changes in interest rates by the interest rate swaps, which have a notional amount of $200.0 million. A hypothetical 100 basis point change in the interest rate would have ~~a $1.6 million effect~~had no impact on our pretax income, on an annualized basis, including the effect of the interest rate ~~swap.~~swaps.

On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 1.900%.

On January 30, 2020, we entered into a forward interest rate swap agreement effective December 31, 2019 and ending December 31, 2024, with a notional amount of $50.0 million. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 1.500%.

~~Table of Contents~~

On March 16, 2020, we entered into a forward interest rate swap agreement effective February 28, 2020 and ending February 28, 2025, with a notional amount of $100.0 million. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 0.885%.

We also have exposure to changes in interest rates associated with the promissory note assumed on June 30, 2017 in connection with our purchase of an aircraft, which has variable interest rates tied to LIBOR. At March 31, ~~2020,~~2021, the outstanding principal amount of the promissory note was ~~$3.7~~$3.2 million and carried an interest rate of ~~3.6%~~2.1%. A hypothetical 100 basis point change in this interest rate would not have a material effect on our pretax income. At December 31, ~~2019,~~2020, the outstanding principal amount of the promissory note was ~~$3.9~~$3.3 million and carried an interest rate of ~~3.7%~~2.1%. A hypothetical 100 basis point change in the interest rate as of December 31, ~~2018~~2020 would not have had a material effect on our pretax income.

We do not use derivative instruments for trading or other speculative purposes. From time to time, we invest excess cash in short-term marketable securities. These investments principally consist of overnight sweep accounts. Due to the short maturity of these investments, we have concluded that we do not have material market risk exposure.

We have an investment in the form of 1.69% convertible debt in Shorelight Holdings, LLC, a privately-held company, which we account for as an available-for-sale debt security. As such, the investment is carried at fair value with unrealized holding gains and losses excluded from earnings and

Table of Contents

reported in other comprehensive income. As of March 31, ~~2020,~~2021, the fair value of the investment was ~~$62.2~~$58.0 million, with a total cost basis of $40.9 million. At December 31, ~~2019,~~2020, the fair value of the investment was ~~$49.5~~$64.4 million, with a total cost basis of ~~$27.9~~$40.9 million.

We have a preferred stock investment in Medically Home Group, Inc., a privately-held company, which we account for as an equity security without a readily determinable fair value using the measurement alternative. As such, the investment is carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment. Any unrealized holding gains and losses resulting from observable price changes are recorded in our consolidated statement of operations. As of March 31, 2021 and December 31, 2020, the carrying value of the investment was $6.7 million, with a total cost basis of $5.0 million. Following our purchase, ~~there has been no~~we have not identified any impairment ~~nor any observable price changes to~~of our investment.

See Note 10 “Fair Value of Financial Instruments” for further information on our long-term ~~investments.~~investments in Shorelight Holdings, LLC and Medically Home Group, Inc.



ITEM 4.			CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the

effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities

Exchange Act of 1934, as amended (the "Exchange Act")) as of March 31, ~~2020.~~2021. Based on this evaluation, our Chief Executive Officer

and Chief Financial Officer have concluded that, as of March 31, ~~2020,~~2021, our disclosure controls and procedures were effective in

recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports we file or

submit under the Exchange Act, and such information is accumulated and communicated to management as appropriate to allow timely

decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

~~There has been no change~~During the quarter ended March 31, 2021, we completed the implementation of a new cloud-based enterprise resource planning (“ERP”) system which replaced much of our existing core financial, operating, and human resource systems. The ERP system is designed to accurately maintain our financial records, enhance the flow of financial information, improve data management, and provide timely information to our management team. As a result of this implementation, we modified certain existing internal controls over financial reporting as well as implemented new controls and procedures related to the new ERP system.

The implementation of the ERP system and related changes described above are changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the ~~three months~~quarter ended March 31, ~~2020~~2021, that ~~has~~have materially affected, or isare reasonably likely to materially affect our internal control over financial reporting.

PART II—OTHER INFORMATION



ITEM 1.			LEGAL PROCEEDINGS.

~~The information required by this Item is incorporated by reference from Note 13 "Commitments, Contingencies and Guarantees" included in Part I, Item 1 of this Quarterly Report on Form 10-Q.~~

~~Table of Contents~~



ITEM 1A.			RISK FACTORS.

~~The following information updates, and should be read in conjunction with, the information disclosed in~~See Part 1, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2019 (the “2019 Annual Report”),~~2020, which was filed with the Securities and Exchange Commission on February ~~26, 2020.~~

~~Our results of operations have been adversely affected and, in the future, could be materially adversely impacted by the coronavirus (COVID-19) pandemic.~~

The worldwide spread of coronavirus (COVID-19) has created significant volatility, uncertainty and disruption to the global economy. The extent to which the COVID-19 pandemic impacts our business, operations and financial results will depend on numerous evolving factors that we may not be able to accurately predict, including:

~~the duration and scope~~23, 2021, for a complete description of the ~~pandemic;~~material risks we face.

~~governmental, business and individuals’ actions that have been and continue to be taken in response to the pandemic;~~

~~the effect on our clients and client demand for our services and solutions, including the effect on the healthcare industry which is an area of significant focus for our business;~~

~~the impact on our key third-party vendors;~~

~~the effect on the businesses in which we have invested;~~

~~our ability to sell and provide our services and solutions and maintain adequate utilization levels, including as a result of travel restrictions and people working from home;~~

~~the ability of our clients to pay for our services and solutions;~~

any disruption to the Internet and related systems, which may impact our ability to provide our services and solutions remotely, and increased vulnerability to hackers or third parties seeking to disrupt operations; and

~~any closures of our clients’ offices and facilities.~~

Additionally, in some instances, clients have slowed down decision making, delayed planned work or are seeking to reduce the scope of current engagements or terminate existing agreements, which may continue. Any of these events could cause or contribute to the risks and uncertainties enumerated in our 2019 Annual Report and could materially adversely affect our business, financial condition, results of operations and/or stock price.

Our goodwill and other intangible assets represent a substantial amount of our total assets, and we may be required to recognize a non-cash impairment charge for these assets if the performance of one or more of our reporting units falls below our expectations.

Our total assets reflect a substantial amount of intangible assets, primarily goodwill. At December 31, 2019, goodwill and other intangible assets totaled $678.3 million, or 61%, of our total assets. During the first quarter of 2020, we incurred non-cash pretax goodwill impairment charges totaling $59.8 million related to our Strategy and Innovation and Life Sciences reporting units within our Business Advisory segment, as discussed below, resulting in a total goodwill and other intangible asset balance of $614.4 million, or 52%, of our total assets as of March 31, 2020. The goodwill results from our acquisitions, representing the excess of the fair value of consideration transferred over the fair value of the net assets acquired. We test goodwill for impairment at the reporting unit level, annually and whenever events or circumstances make it more likely than not that an impairment may have occurred.

~~Table of Contents~~

charge related to the Strategy and Innovation reporting unit reduced the goodwill balance of the reporting unit to $37.5 million. The $9.9 million non-cash pretax charge related to the Life Sciences reporting unit reduced the goodwill balance of the reporting unit to zero.

Refer to “Critical Accounting Policies” within Part I - Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Note 4 “Goodwill and Intangible Assets” within the notes to our consolidated financial statements for further discussion of our goodwill, intangible assets, and impairment tests performed in 2020.



ITEM 2.			UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Our Stock Ownership Participation Program, 2012 Omnibus Incentive Plan, and 2004 Omnibus Stock Plan, which was replaced by the 2012 Omnibus Incentive Plan, permit the netting of common stock upon vesting of restricted stock awards to satisfy individual tax withholding requirements. During the quarter ended March 31, ~~2020,~~2021, we reacquired ~~120,000~~165,203 shares of common stock with a weighted average fair market value of ~~$59.44~~$51.47 as a result of such tax withholdings.

We currently have a share repurchase program permitting us to repurchase up to ~~$125~~$50 million of our common stock through ~~October~~December 31, ~~2020~~2021 (the ~~"Share~~"2020 Share Repurchase Program"). The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our line of credit, general market and business conditions, and applicable

Table of Contents

legal requirements.

The following table provides information with respect to purchases we made of our common stock during the quarter ended March 31, ~~2020.~~2021.


Period	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Dollar Value of Shares that may yet be Purchased under the Plans or Programs (2)
January 1, 2021 - January 31, 2021	10,479	$	58.94	—	$	44,974,137
February 1, 2021 - February 28, 2021	95	$	58.95	—	$	44,974,137
March 1, 2021 - March 31, 2021	400,347	$	52.59	245,718	$	31,791,094
Total	410,921	$	52.76	245,718

(1)The number of shares repurchased included 10,479 shares in January 2021, 95 shares in February 2021, and 154,629 shares in March 2021 to satisfy employee tax withholding requirements. These shares do not reduce the repurchase authority under the 2020 Share Repurchase Program.

(2)As of the end of the period.

Period
Total Number of Shares Purchased ⁽¹⁾

Average Price
Paid per Share

Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs

Dollar Value of Shares
that may yet be
Purchased under the
Plans or Programs ⁽²⁾
January 1, 2020 - January 31, 2020 134,346
$ 67.90
125,463
$ 12,408,601
February 1, 2020 - February 29, 2020 188,547
$ 65.55
188,535
$ 43,572
March 1, 2020 - March 31, 2020 111,105
$ 58.70
—
$ 43,572
Total 433,998
$ 64.53
313,998


~~(1)~~	The number of shares repurchased includes 8,883 shares in January 2020, 12 shares in February 2020 and 111,105 shares in March 2020 to satisfy employee tax withholding requirements. These shares do not reduce the repurchase authority under the Share Repurchase Program.


~~(2)~~	~~As of the end of the period.~~



ITEM 3.			DEFAULTS UPON SENIOR SECURITIES.

None.



ITEM 4.			MINE SAFETY DISCLOSURES.

Not applicable.



ITEM 5.			OTHER INFORMATION.

None.

Table of Contents



ITEM 6.			EXHIBITS.

(a) The following exhibits are filed as part of this Quarterly Report on Form 10-Q.

Incorporated by Reference

Exhibit
Number

Exhibit Description

Filed
herewith

Furnished
herewith

Form

Period
Ending

Exhibit

Filing
Date

10.1

Form of Retention Bonus Agreement

8-K

10.1

4/16/2021

31.1

Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

~~Incorporated by Reference~~

~~Exhibit~~

~~Number~~

~~Exhibit Description~~

~~Filed~~

~~herewith~~

~~Furnished~~

~~herewith~~

~~Form~~

~~Period~~

~~Ending~~

~~Exhibit~~

~~Filing~~

~~Date~~

~~10.1~~

~~Senior Management Agreement by and between Huron Consulting Group Inc. and Ernest W. Torain, Jr.~~

~~31.1~~

~~Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.~~

~~31.2~~

~~Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.~~

~~32.1~~

~~Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.~~

~~32.2~~

~~Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.~~

~~101.INS~~

~~Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.~~

~~101.SCH~~

~~Inline XBRL Taxonomy Extension Schema Document~~

~~101.CAL~~

~~Inline XBRL Taxonomy Extension Calculation Linkbase Document~~

~~101.LAB~~

~~Inline XBRL Taxonomy Extension Label Linkbase Document~~

~~101.PRE~~

~~Inline XBRL Taxonomy Extension Presentation Linkbase Document~~

~~101.DEF~~

~~Inline XBRL Taxonomy Extension Definition Linkbase Document~~

~~104~~

~~Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)~~

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Huron Consulting Group Inc.

(Registrant)

Date:

~~April 30, 2020~~May 4, 2021

/S/ JOHN D. KELLY

John D. Kelly

Executive Vice President,

Chief Financial Officer and Treasurer


				Page
Part I – Financial Information

			~~Page~~
~~Part I – Financial Information~~

Item 1.	Consolidated Financial Statements (Unaudited)
		Consolidated Balance Sheets		1
		Consolidated Statements of Operations and Other Comprehensive Income		2
		Consolidated Statements of Stockholders’ Equity		3
		Consolidated Statements of Cash Flows		4
		Notes to Consolidated Financial Statements		5

Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations		2021

Item 3.		Quantitative and Qualitative Disclosures About Market Risk		3536

Item 4.		Controls and Procedures		3637

Part II – Other Information

Item 1.		Legal Proceedings		3637

Item 1A.		Risk Factors		37

Item 2.		Unregistered Sales of Equity Securities and Use of Proceeds		3837

Item 3.		Defaults Upon Senior Securities		38

Item 4.		Mine Safety Disclosures		38

Item 5.		Other Information		38

Item 6.		Exhibits		39

Signature				40



		As of March 31, 2020				As of December 31, 2019
	Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	3 to 13	$	87,379	$	64,265	$	87,577	$	61,882
Trade names	5 to 6	28,930		26,192		28,930		25,894
Technology and software	5	5,440		4,456		5,694		4,321
Non-competition agreements	5	2,220		1,559		2,220		1,447
Customer contracts	2	800		170		800		52
Total		$	124,769	$	96,642	$	125,221	$	93,596



	March 31, 2020			December 31, 2019
Senior secured credit facility	$	448,000		$	205,000
Promissory note due 2024	3,722			3,853
Total long-term debt	$	451,722		$	208,853
Current maturities of long-term debt	(533		)	(529		)
Long-term debt, net of current portion	$	451,189		$	208,324



	Three Months Ended March 31, 2019
Contractual interest coupon	$	781
Amortization of debt discount	2,120
Amortization of debt issuance costs	315
Total interest expense	$	3,216



	Convertible Debt Investment
Balance as of December 31, 2019	$	49,542
Purchases	13,000
Change in fair value of convertible debt investment	(348		)
Balance as of March 31, 2020	$	62,194



Reporting Unit	Carrying Value of Goodwill
Healthcare	$	428,729
Education	103,889
Business Advisory	16,094
Strategy and Innovation	37,523
Life Sciences	—
Enterprise Solutions and Analytics	—
Total	$	586,235



Period	Total Number of Shares Purchased ⁽¹⁾	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Dollar Value of Shares that may yet be Purchased under the Plans or Programs ⁽²⁾
January 1, 2020 - January 31, 2020	134,346	$	67.90	125,463	$	12,408,601
February 1, 2020 - February 29, 2020	188,547	$	65.55	188,535	$	43,572
March 1, 2020 - March 31, 2020	111,105	$	58.70	—	$	43,572
Total	433,998	$	64.53	313,998